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ABSTRACT 
People with coeliac disease have to maintain a gluten-free diet, which means excluding wheat, barley 
and rye prolamin proteins from their diet. Immunochemical methods are used to analyse the harmful 
proteins and to control the purity of gluten-free foods. In this thesis, the behaviour of prolamins in 
immunological gluten assays and with different prolamin-specific antibodies was examined. The 
immunoassays were also used to detect residual rye prolamins in sourdough systems after enzymatic 
hydrolysis and wheat prolamins after deamidation. The aim was to characterize the ability of the gluten 
analysis assays to quantify different prolamins in varying matrices in order to improve the accuracy of 
the assays. 
Prolamin groups of cereals consist of a complex mixture of proteins that vary in their size and amino 
acid sequences. Two common characteristics distinguish prolamins from other cereal proteins. Firstly, 
they are soluble in aqueous alcohols, and secondly, most of the prolamins are mainly formed from 
repetitive amino acid sequences containing high amounts of proline and glutamine. The diversity 
among prolamin proteins sets high requirements for their quantification. In the present study, prolamin 
contents were evaluated using enzyme-linked immunosorbent assays based on - and R5 antibodies. In 
addition, assays based on A1 and G12 antibodies were used to examine the effect of deamidation on 
prolamin proteins. The prolamin compositions and the cross-reactivity of antibodies with prolamin 
groups were evaluated with electrophoretic separation and Western blotting.  
The results of this thesis research demonstrate that the currently used gluten analysis methods are not 
able to accurately quantify barley prolamins, especially when hydrolysed or mixed in oats. However, 
more precise results can be obtained when the standard more closely matches the sample proteins, as 
demonstrated with barley prolamin standards. The study also revealed that all of the harmful prolamins, 
i.e. wheat, barley and rye prolamins, are most efficiently extracted with 40% 1-propanol containing 1% 
dithiothreitol at 50 °C. The extractability of barley and rye prolamins was considerably higher with 
40% 1-propanol than with 60% ethanol, which is typically used for prolamin extraction.  
The prolamin levels of rye were lowered by 99.5% from the original levels when an enzyme-active rye-
malt sourdough system was used for prolamin degradation. Such extensive degradation of rye 
prolamins suggest the use of sourdough as a part of gluten-free baking. Deamidation increases the 
diversity of prolamins and improves their solubility and ability to form structures such as emulsions 
and foams. Deamidation changes the protein structure, which has consequences for antibody 
recognition in gluten analysis. According to the resuts of the present work, the analysis methods were 
not able to quantify wheat gluten after deamidation except at very high concentrations. Consequently, 
deamidated gluten peptides can exist in food products and remain undetected, and thus cause a risk for 
people with gluten intolerance.   
The results of this thesis demonstrate that current gluten analysis methods cannot accurately quantify 
prolamins in all food matrices. New information on the prolamins of rye and barley in addition to 
wheat prolamins is also provided in this thesis, which is essential for improving gluten analysis 
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1   INTRODUCTION 
The main storage proteins of wheat, barley and rye are called prolamins. The function of storage 
proteins is to store nitrogen, carbon and sulphur in the grain endosperm. Prolamins of wheat have the 
special characteristic of forming viscoelastic dough, which is important in wheat baking, whereas 
prolamins of other cereal species lack this property. Unfortunately, these same proteins are also 
harmful for gluten-sensitive people, e.g. for people with coeliac disease. In the context of coeliac 
disease, prolamins of wheat, barley and rye are often called gluten, and hence the term gluten-free is 
generally used. This thesis research focused on the immunological analysis of these proteins.  
Many studies have been published on the relationship between prolamins and coeliac disease, and 
extensive knowledge of the pathogenesis of coeliac disease has been gained in recent years (reviewed 
in, e.g., Koning et al. 2005, Briani et al. 2008). Coeliac disease is initiated by the ingestion of prolamin-
containing food. During digestion, gastric and pancreatic enzymes break proteins down into small 
peptides. In people with coeliac disease, these peptides initiate a reaction chain that leads to mucosal 
villous atrophy and crypt hyperplasia. In order to avoid this, coeliac patients have to maintain a diet 
free of prolamins, i.e. a gluten-free diet. Such a diet is currently the only treatment for coeliac disease. 
Gluten-free products are usually made from rice, maize or buckwheat. Industrially purified wheat 
starch is also commonly used in gluten-free baking. This special starch is manufactured gluten-free and 
is therefore suitable for most coeliac patients. Nevertheless, traces of prolamins remain in the starch. In 
addition, some contamination from the harmful cereals may occur in various gluten-free food products 
(Thompson et al. 2010). The studies of present thesis focused on the special circumstances that occur 
when prolamins are analysed from different food matrices and from processed foods. 
The quantitative analysis of prolamins is mainly based on immunological methods, but mass 
spectrometric and chromatographic techniques have also been introduced (e.g. Wieser et al. 1998, 
Sealey-Voyksner et al. 2010). Most of the immunological methods that are used today are based on the 
antibody recognition of wheat gliadin or peptides derived from wheat. Wheat is the most common 
cereal throughout the world, and wheat proteins have received a considerable amount of research 
attention.  Although  prolamins  of  barley  and  rye  are  also  considered  harmful  for  people  with  coeliac  
disease, they have not been studied as much in this context. Since prolamins of all of the harmful 
cereals resemble each other, it is incorrectly assumed that they can be analyzed in the same way.  
Prolamins can be degraded to reduce their harmfulness to gluten-intolerant people. This has been 
carried out by degrading them with specific enzymes into small peptides that no longer have 
immunological activity (Mitea et al. 2008a). Because of the tight structure of prolamins caused by their 
high proline content, the enzymes of gastrointestinal system are incapable of efficiently hydrolysing 
prolamins (Shan et al. 2005). However, cereal grains themselves contain enzymes that are able to 
degrade prolamins under optimal conditions (Loponen et al. 2004). These enzymes have been 
suggested to be used as an oral therapy, or they could offer a tool when developing new gluten-free 
cereal-based products, an approach that was examined in this thesis research.   
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Wheat storage proteins, which are also known as gluten, have many special characteristics that favour 
their use in various food products. Because a large amount of gluten is generated during the 
manufacture of starch, it has a relatively low price. The low solubility of gluten, however, limits its use. 
Numerous techniques have been developed to modify proteins to have more desired characteristics, 
such as increased solubility. Deamidation increases the potential use of proteins in various food 
products, e.g. to improve the structure or increase the protein content. This may turn out to be 
problematic for people on a gluten-free diet, since gluten proteins may be found in unexpected sources 
such as meat, fish or milk products (Day et al. 2006). Deamidation also changes the immunological 
behaviour of proteins, and the deamidation of gluten peptides by a tissue transglutaminase (tTG) is 
described to be an important part of the pathogenesis of coeliac disease (Molberg et al. 1998). It is not 
precisely known whether industrial deamidation increases or decreases their harmfulness to people with 
gluten intolerance, but either way, deamidation influences the detection of proteins by antibody-based 
immunological assays. A study included in this thesis focused on this phenomenon.  
This thesis reviews the literature on the characteristics of prolamin proteins of wheat, barley, rye and 
oats and the literature relating to prolamins and coeliac disease. In addition, the different gluten-
detecting antibodies and immunological gluten analysis methods are reviewed. Finally, the literature on 
gluten-free legislation and recommendations and their influence on the gluten-free diet and the variety 
of gluten-free products is reviewed. The experimental part focuses on qualitative and quantitative 
studies on prolamins using immunological and electrophoretic analysis methods. The aim of this study 
was to improve gluten detection in the analysis of different gluten-free foods.  
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2   REVIEW OF THE LITERATURE 
2.1   Prolamins in cereals 
Prolamins of wheat, barley and rye are storage proteins located in the grain endosperm. They belong to 
the prolamin superfamily together with several plant food allergens such as 2S albumins, nonspecific 
lipid transfer proteins and cereal alpha-amylase/trypsin inhibitors (Breiteneder and Radauer 2004). 
Osborne was first to suggest the name prolamins for this group of cereal proteins because of their high 
content of proline and amide nitrogen (Shewry and Tatham 1999). The prolamin superfamily was 
named after the cereal prolamins. Osborne characterized cereal prolamins as freely soluble in relatively 
strong ethyl alcohol, but insoluble in absolute alcohol, slightly soluble in water, and easily soluble in 
very dilute acids and bases (Osborne 1907).  
Wheat  storage  proteins  are  also  known  as  gluten.  The  term  gluten  is  sometimes  used  with  similar  
proteins from other cereals, such as barley and maize, even though they lack the rheological 
characteristics of wheat gluten. In the context of coeliac disease, however, gluten refers to the harmful 
proteins of wheat, barley and rye. In legislation, the term gluten is defined in different ways. The 
Codex definition of gluten is a “protein fraction from wheat, rye, barley, oats or their crossbred 
varieties and derivatives thereof, to which some persons are intolerant and that is insoluble in water and 
0.5M NaCl” (Codex Stan 118-1979). The U.S. Food and Drug Administration (FDA) defines gluten 
more from the clinical perspective as “the proteins that naturally occur in a prohibited grain and that 
may cause adverse health effects in persons with coeliac disease (e.g., prolamins and glutelins)” (FDA 
2007). The term ‘prohibited grain’ refers to wheat, rye and barley, including any species belonging to 
their genera, or their crossbred hybrids. In this thesis, the term prolamin is preferred over gluten for the 
cereal proteins that are harmful to coeliac patients. The prolamin fraction of each cereal has a specific 
name: wheat prolamins are termed gliadins and glutenins, barley prolamins are hordeins and those from 
rye are secalins. The prolamin fractions of cereals that are not harmful to people with coeliac disease 
also have their own names: oat prolamins are called avenins, maize prolamins are zeins and rice 
prolamins oryzeins. 
The function of storage proteins is to store carbon and nitrogen for germination. They contain high 
amounts of the amino acids glutamine and glutamic acid (about 40 mol %), and proline (about 20 mol 
%), but are low in lysine (less than 1 mol %) (Shewry et al. 1992). A special characteristic of proline is 
its ability to make -turns. These turns form a tighter helix than an -helix and thus enable proteins to 
be packed more efficiently into a small space. This is convenient for a plant to store vital amino acids, 
but makes it difficult for enzymes to hydrolyse the tight structures of prolamins. As a consequence, 
these proteins are poorly degraded by the gastrointestinal enzymes and remain relatively large peptides 
when entering the small intestine, where coeliac disease is manifested. The ability of prolamins to resist 
degradation was suggested to be one reason for their harmful effect on susceptible people (Shan et al. 
2002). 
All cereals contain prolamins. However, only the prolamins of wheat, barley and rye are harmful to 
people with gluten intolerance. One explanation could be phylogenetic. Wheat, barley and rye are 
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closely related to each other and they belong to the tribe of Triticeae (Figure 1). The prolamins of 
wheat have been extensively studied and their association with coeliac disease has been confirmed. The 
other harmful cereal species, barley and rye, have not gained such attention. However, their prolamins 








Figure 1. The common cereals in the grass family. Wheat (Triticum), barley (Hordeum) and rye 
(Secale) belong to the same tribe of Triticeae,  whereas  oats  belong  to  Poeae.  Maize  (Zea),  sorghum 
(Sorghum) and millet (Panicum, Pennisetum, Setaria, etc.) belong to the separate subfamily of 
Panicoideae, and rice (Oryza) to the Ehrhartoideae (data from www.uniprot.org/taxonomy). 
Wheat is one of the main components of Western diets. Wheat gluten has special characteristics that no 
other cereal protein group have. It is able to form a viscoelastic dough, which is the basis for wheat 
baking. Because of the unique characteristics of wheat gluten, in addition to the increased demand for 
vegetable protein, it is used in many food products, including as a thickener in sauces and soups and an 
extender or filler in meat and fish products (Day et al. 2006). The gluten protein fraction can also be 
modified to increase its food-use potential. In addition to the wide use of wheat-based products, barley 
has recently also attracted new interest as a food ingredient because of its nutritional value as a 
wholegrain material (Baik and Ullrich 2008). The wholegrain foods overall have become more popular, 
since they are associated with increased satiety and weight loss. Barley contains -glucan, which has 
found to have a lowering effect on blood cholesterol levels and the glycemic index. Rye-based products 
are also widely used, especially in Eastern Europe. Consequently, our diet is very much based on the 
harmful cereals, and maintaining a gluten-free diet can be quite cumbersome. 
Prolamins consist of multiple proteins that can be divided to monomeric and polymeric groups. 
Monomeric prolamins are soluble in aqueous alcohols, whereas polymeric prolamins need the 
reduction of interchain disulphide bonds before they can be solubilized in aqueous alcohol. The 
disulphide bonds can be broken by reductive agents or by acid or enzyme treatments. Disulphide bonds 
are typical in the structure of storage proteins. Monomeric prolamins contain intramolecular disulphide 
bonds, whereas polymeric prolamins contain intermolecular disulphide bonds in addition to 
intramolecular bonds (Figure 2). The disulphide bonds hold the proteins closer together and improve 
the packing of proteins in a smaller space. The occurrence and formation of disulphide bonds in wheat 









Figure 2. Positions of disulphide bonds in monomeric and polymeric prolamins. 
Prolamins can be divided into groups based on their sulphur content, size or sequence homologies. 
Shewry and Tatham (1990) divided prolamins based on their sulphur content into S-poor, S-rich and 
high molecular weight (HMW) prolamins, whereas Wieser (2000) divided prolamins into three groups 
based on their size: HMW (80 000–120 000 g/mol), medium molecular weight (MMW) (52 000–
80 000 g/mol) and low molecular weight (LMW) (30 000–52 000 g/mol) groups. The HMW group 
consists of HMW glutenin subunits of wheat, HMW secalins and D-hordeins. The MMW group consist 
of  -type  gliadins  and  secalins  and  C-hordeins  of  barley.  The  LMW  group  consists  of  -  and  -
gliadins, -secalins (monomeric -40 and polymeric -75) and -hordeins. The prolamin subgroups are 
described in more detail below. 
2.1.1   Wheat 
Wheat grain usually contains about 12–14% of protein. Approximately 80% of the total protein content 
of wheat grain is prolamins. About half of these are gliadins, the other half being glutenins (Huebner 
1970). There is, however, considerable variation in these relative proportions (Wieser and Koehler 
2009). Gliadins consist of monomeric proteins whereas glutenins have a polymeric nature. 
Wheat prolamins are divided into -, -, - and -gliadins and HMW and LMW glutenin subunits 
according to the electrophoretic mobility at acid pH. The - and -gliadins are often combined together 
and  simply  referred  to  as  -gliadins  because  of  the  high  similarity  of  their  N-terminal  amino  acid  
sequences.   
Gliadins 
Monomeric wheat prolamins, gliadins, are divided into subgroups of -, - and -gliadins.  
The group of -gliadins is generally the major group, comprising between 44 and 60% of the total 
gliadin content. The second largest group is -gliadins (31–46%), and together these groups account for 
about 80% of wheat gliadins (Shewry and Tatham 1990). The sizes of - and -gliadins are 
approximately 36 000–44 000 g/mol, they contain about 250–300 amino acid residues and are rich in 
sulphur. The -gliadins are typical for wheat and they are thought to be the most harmful fraction for 
people with coeliac disease. Although rye and barley are considered as harmful for coeliacs as wheat, 
they do not contain similar proteins (Shewry and Tatham 1990). The -gliadins contain long repeats of 
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glutamine residues along with typical repetitive domains (Table 1). The -gliadins are also repetitive 
and mostly monomers; however, polymeric forms also exist (Shewry and Tatham 1990).  
The rest of the gliadins, about 10–20%, are sulphur-poor -gliadins (Shewry and Halford 2002). Their 
sizes are between 44 000–78 000 g/mol. Due to the highly repetitive nature of -gliadins, about 80% of 
their amino acid content is glutamine, glutamic acid, proline and phenylalanine residues. Since -
gliadins are poor in sulphur and do not therefore contain disulphide bonds in their structure, they retain 
their solubility after heat treatment. Their solubility was reported to remain the same in processed 
samples as the solubility of sulphur-containing - and -gliadin decreased considerably (Skerritt and 
Smith 1985). Immediate allergic reactions have been associated with -gliadins (Palosuo et al. 2001).  
Altogether, about 30 individual proteins can be distinguished by two-dimensional electrophoresis of the 
gliadin fraction of wheat (Madgwick et al. 1992). 
Glutenins 
Glutenins are polymeric, consisting of low molecular weight glutenin subunits (LMW-GS) and high 
molecular weight glutenin subunits (HMW-GS).  
The LMW-GS can be divided into B-, C- and D-types based on their electrophoretic mobility (Jackson 
et al. 1983). B-type subunits are the major group of LMW glutenins. C-type LMW-GS are similar to - 
and -gliadins, whereas D-type LMW-GS resemble -gliadins. The molecular weights of LMW-GS are 
similar to - and -gliadins: the molecular weights of B-type subunits are 40 000–50 000 g/mol, those 
of C-type subunits are 30 000–40 000 g/mol, and the weights of D-type subunits are slightly higher 
than  the  weights  of  B-type  subunits  (Lew  et  al.  1992).  The  LMW  glutenins  are  closely  related  to  
gliadins, the main difference being their higher tendency to aggregate. Many antibodies raised against 
gliadins also recognize LMW glutenins (Skerritt and Robson 1990). 
 
About 10% of wheat storage proteins are HMW glutenins (Shewry and Tatham 1990). The subunits of 
glutenins are located in seeds in large polymers stabilized with disulphide bonds. These polymers are 
about 106–107 g/mol in size, and belong to the largest polymers in nature (Wahlund et al. 1996). The 
HMW-GS consist of approximately 600–800 amino acids, with high amounts of glycine, glutamine and 
proline. The HMW-GS can be divided into x-types and y-types. The size of the x-types is typically 83 
000–89 000 g/mol and the y-types 68 000–73 000 g/mol, as determined by mass spectrometry (MS) 
(Hickman et al. 1995). The variability in HMW-GS between wheat cultivars is high. About 20 different 
subunits were distinguished by sodium dodecyl sulphate-polyacryl amide gel electrophoresis (SDS-
PAGE) (Payne et al. 1981). However, most cultivars contain from 3 to 5 subunits with molecular 
weights between 82 000 and 125 000 g/mol.  
Polymeric prolamins have an important role in the formation of the gluten network. The relative 
amount of polymeric proteins in gluten correlates with dough strength, and the composition of subunits 
of HMW glutenins has been used to predict the baking qualities of wheat cultivars (Payne et al. 1979).  
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2.1.2   Barley 
Estimates of the amount of prolamin in barley grain vary considerably. The reported figures are 
between 30 to 50% of the total protein content. However, the prolamin content is most likely higher, 
since only about 10–20% of the total proteins belong to the water- and salt soluble albumins (9–13%) 
and globulins (2–6%) (Rhodes and Gill 1980). Barley storage proteins are termed hordeins and they 
can be divided into four groups: B-, C-, D-and -hordeins. Most of the barley storage proteins (80%) 
belong to the sulphur-rich proteins, mainly to the B-hordeins. 
Monomeric hordeins 
The C- and -hordeins are monomeric prolamins of barley.  
C-hordeins are approximately 55 000–70 000 g/mol in size (Shewry and Tatham 1990). They are the 
second largest group of hordeins in barley, comprising about 10–20% of the hordeins (Tatham and 
Shewry 1995). Their sequence consists of about 440 amino acid residues and is almost entirely 
composed of repeats of the octapeptide PQQPFPQQ (Shewry and Tatham 1990). The amino acid 
content of C-hordein is comparable to this sequence: 40 mol-% glutamine, 30 mol-% proline and 8–9 
mol-% phenylalanine. C-hordeins are poor in sulphur and do not contain cysteine (Shewry and Tatham 
1990). The isoelectric points of the C-hordeins are in the pH range 5.0–6.0 (Shewry et al. 1978). 
Studies using circular dichroism spectroscopy have suggested C-hordeins to have an unusual secondary 
structure with regularly repeated -turns in the absence of an -helix and -sheet (Tatham et al. 1985, 
Field et al. 1986). The structure seems to be stabilized by strong hydrophobic interactions and 
hydrogen bonding. 
The -hordeins are approximately 36 000–44 000 g/mol in size, consisting 250–300 amino acid 
residues  (Shewry  and  Tatham  1990).  Similar  to  the  -gliadins  of  wheat,  some  of  the  -hordeins  are  
found in polymers, most of them being monomeric (Shewry et al. 1985). Similar repetitive units are 
found in -hordeins and C-hordeins (Shewry and Tatham 1990). Only minor amounts of -hordeins are 
present in barley. 
Polymeric hordeins 
Polymeric prolamins of barley are termed B- and D-hordeins.  
Sulphur-rich B-hordeins are the main group of hordeins, making up about 70–80% of the prolamin 
content of barley (Shewry et al. 1985). They are found in polymers, and as subunits they are about the 
same size as -hordeins (36 000–44 000 g/mol) (Shewry and Tatham 1990). B-hordeins are composed 
of a highly polymorphic group of proteins and they are not as repetitive as other hordeins. Less than 
30% of their amino acid sequence contains repeats of PQQP (Shewry and Tatham 1990). The 
isoelectric points of the B-hordeins are in the pH range 6.0–8.0 (Shewry et al. 1978). The B-hordeins 
are most closely related to the low molecular mass subunits of wheat glutenin. 
D-hordeins are similar to the HMW subunits of wheat. The molar masses of D-hordein subunits are 
about 90 000–110 000 g/mol. D-hordeins are high in glycine, glutamine and proline (Shewry and 
Tatham 1990), and because of the unique repetitive units D-hordeins contain considerable amounts of 
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threonine (Shewry and Tatham 1999). D-hordeins make up about 7–8% of the hordeins (Marchylo et 
al. 1986).  
2.1.3   Rye 
The protein content of rye grain is somewhat lower than those in wheat and barley, being about 10% of 
the grain. Rye has a unique composition of proteins, and contains significantly higher proportions of 
soluble proteins, i.e. albumins and globulins, compared to wheat and barley. In studies on cereal protein 
compositions, it has been observed that nitrogen soluble in NaCl and water made up 40% of the total 
nitrogen of rye flour, whereas only 20% of wheat nitrogen was soluble under the same conditions 
(Charbonnier et al. 1981). Based on high-performance liquid chromatography (HPLC) studies on the 
protein composition of rye, about 26% of total proteins were found to fall into the group of salt-soluble 
proteins (Gellrich et al. 2003), which is about twice as much as found in wheat flour.  
Rye prolamins are called secalins. They are divided into four types: HMW, -75,  and -40 secalins. 
All of these groups have been thoroughly studied by Gellrich et al. (2003, 2004a, 2004b, 2005). In 
earlier studies, rye prolamins were divided similarly to barley prolamins into three groups based on 
their size: A-secalins (about 16 000 g/mol), B-secalins (about 29 000 g/mol, similar to - and -
gliadins) and C- secalins (about 38 000 g/mol, similar to -gliadins) (Charbonnier et al. 1981).  
Monomeric secalins 
The monomeric secalins are made up of -40 and -secalins.  
The monomeric -40 secalins account for about 24% of the total secalin fraction, and their molecular 
weights are about 36 000–44 000 g/mol (Shewry and Tatham 1999, Gellrich et al. 2003). The -40 
secalins appeared homologous to -gliadin of wheat (Shewry et al. 1982), which was later confirmed 
by a study on N-terminal amino acid sequences (Gellrich et al. 2005).  
Monomeric -secalins account for about 17% of the total secalin fraction of rye (Gellrich et al. 2003). 
Based on the N-terminal amino acid sequences, -secalins are homologous to corresponding -gliadins 
of wheat. The molecular weight of -secalins is about 48 000–53 000 g/mol (Shewry and Tatham 
1990, Gellrich et al. 2003). The -secalins are poor in sulphur. They are almost entirely composed of 
the repetitive sequence PQQPFPQQ, similar to C-hordein in barley (Shewry and Tatham 1999). 
Approximately 80 mol-% of their amino acid composition is made up of glutamine, glutamic acid, 
proline and phenylalanine (Shewry and Tatham 1990). 
Polymeric secalins 
Polymeric secalins are made up of -75 and HMW secalins.  
The -75 secalins made up about 46% of the total secalins and their molecular weights are about 70 000 
g/mol (Gellrich et al. 2003). The -75 secalins are similar to -gliadin, but their glutamine and proline 
contents are higher. Therefore, they form a unique group of prolamins. The higher glutamine and 
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proline contents are thought to be due to the higher contents of repetitive sequences in -75 secalins 
than in -40 secalins. The -75 secalins contain one cysteine residue in the N-terminal, which makes 
them able to form similar bonds and structures to LMW glutenins (Gellrich et al. 2004b). However, -
75 secalins do not contain cysteine in the C-terminal, which prevents the formation of larger protein 
aggregates similar to the gluten network. 
HMW  secalins  account  for  about  7%  of  the  total  secalins.  The  molecular  weights  of  HMW  secalin  
subunits are about 100 000 g/mol (Shewry et al. 1983). HMW secalins appeared similar to HMW 
gliadins when comparing their N-terminal amino acid sequences (Gellrich et al. 2003). Rye, however, 
does not contain aggregated sulphur-rich prolamins, as do wheat LMW glutenins and barley B-hordeins 
(Shewry and Tatham 1990). HMW secalins consist of high amounts of glycine, glutamine and proline 
(Shewry and Tatham 1990). 
2.1.4   Oats 
The storage proteins of oats are different from those of wheat, barley and rye. Oat storage proteins are 
divided into salt-soluble globulins and alcohol-soluble prolamins, avenins. About twice as many genes 
encode globulins compared to avenins (Chesnut et al. 1989), which is also seen in the amount of 
proteins found in the grain. Avenins comprise about 10% and globulins about 70–80% of the total 
protein of oats. However, the amount of avenins in oats varies considerably, between 4 and 15% of the 
total seed nitrogen. Oat avenins are not considered harmful for people with coeliac disease (e.g. 
Janatuinen et al. 1995). 
Avenins 
Avenins are monomeric and can be divided into two groups based their molecular weights. The 
molecular weights of -avenins are about 12 000–18 000 g/mol and those of -avenins about 22 000–
35 000 g/mol (Jussila et al. 1992). The isoelectric points are between pH 4.5 and 8.0 (Robert et al. 
1983).  
Oat  avenins  are  similar  to  -  and  -gliadins  of  wheat.  Barley  B-hordeins  and  rye  -secalins  are  also  
similar prolamin subgroups (Chesnut et al. 1989). Avenins are high in glutamine and glutamic acid (up 





Table 1. Prolamins of wheat, barley, rye and oats. The one-letter code for amino acids is used in the 
repetitive  domains:  F  =  phenylalanine,  G  =  glycine,  H  =  histidine,  I  =  isoleucine,  L  =  leucine,  P  =  
proline, Q = glutamine, S = serine, T = threonine, V = valine, Y= tyrosine. 
Cereal Prolamin subgroup MW 
x10 g/mol 
% Repetitive domain 
Wheat -Gliadins 28–35 28–33 PQPQPFP and PQQPY (35%) 
-Gliadins 31–35 23–31 PQQPFPQ (40%) 
1,2-Gliadins 39–44 4–7 PQQPFPQQ (90%) 
5-Gliadins 49–55 3–6 QQQ-F/I/L-P 
LMW 32–39 19–25 PQQPPPFS and QQQQPVL (26%) 
HMW subunit x 83–88 4–9 PGQGQQ, GYYPTS-P/L-QQ and GQQ 
HMW subunit y 67–74 3–4 PGQGQQ and GYYPTS-P/L-QQ 
Barley B-Hordeins 36–44 70–80 PQQP (<30%) 
C-Hordeins 55–70  10–20 PQQPFPQQ 
D-Hordeins 90–110 <10 P-G/H-QGQQ, GYYPSXTSPQQ and TTVS 
-Hordeins 36–44 <10 PQQPFPQ 
Rye -Secalins 48–53 17 PQQPFPQQ 
-40 Secalins 36–44 24 QPQQPFP 
-75 Secalins 70 46 QQPPQQPFP 
HMW secalins ~100 7 QQPGQG 
Oats -Avenins 12–18 Minor 
PFVQQQ 
-Avenins 22–35 Major 
Data collected from Tatham et al. 1985, Shewry and Tatham 1990, Jussila et al. 1992, Shewry et al. 
1995, Shewry and Tatham 1999, DuPont et al. 2000, Shewry and Halford 2002, Wieser 2005b, and 
Wieser and Koehler 2008. MW denotes molecular weight. 
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2.2   Prolamin proteins and coeliac disease 
Prolamin proteins of wheat, barley and rye contain multiple proteins, and among them specific 
sequences exist that are harmful for coeliac patients. A common feature for the harmful sequences is 
that they contain high amounts of proline and glutamine. Most of the harmful sequences are found from 
monomeric prolamins, such as -gliadin, but the harmfulness of HMW glutenin subunits has also been 
observed. Harmful sequences have additionally been demonstrated from barley and rye by in vitro and 
in silico studies.   
2.2.1   Coeliac disease in brief 
Even though the first observations of coeliac disease date back hundreds of years, it was only about 60 
years ago when W.K. Dicke wrote in his thesis that wheat gliadin was a harmful substance for coeliac 
patients (Wieser and Koehler 2008). Soon after, barley, rye and oats were also proposed to be harmful 
due to their close relation to wheat. Today, oats are no longer considered harmful for coeliacs. In 
addition, major progress has been made in explaining the pathogenesis of coeliac disease. 
Coeliac disease (gluten intolerance) is a small intestinal enteropathy caused by an inflammatory 
response to prolamins of wheat, barley and rye. The immune reaction induced by ingested prolamins 
causes flattening of the villi in the small intestine and thus leads to inflammation and malabsorption of 
nutrients. Typical symptoms in coeliac disease include chronic diarrhoea, abdominal pain, bloating, 
flatulence, indigestion, weight loss and mouth ulcers; however, long-term malnutrition may lead to 
osteoporosis, developmental delay, educational underperformance, infertility, headaches, predisposition 
to other autoimmune diseases, neurological diseases, fatigue, hair loss, nutrient deficiencies and 
malignancies (Green et al. 2003, Brousse and Meijer 2005, Corazza et al. 2005, Lohi et al. 2009). 
The recommended diagnosis of coeliac disease in the Current Care Guidelines in Finland includes 
gastroenteroscopy to affirm damage in small intestine mucosa (www.kaypahoito.fi). However, the 
presence of certain antibodies is screened when testing for possible coeliac disease. For example, serum 
immunoglobulin A antibodies against tTG or endomysium are good indicators of the disease (Sulkanen 
et al. 1998, Dieterich et al. 1998). There is also a rapid test that detects antibodies from a blood sample 
and can be performed at home if coeliac disease is suspected (Raivio et al. 2007). 
Pathogenesis of coeliac disease 
Coeliac disease has an environmental and a genetic factor. Both factors are needed for the disease to 
occur. The environmental factor is dietary gluten, whereas the most important genetic factor is the 
expression of HLA-DQ2 or HLA-DQ8 molecules. These molecules are found from over 95% of all 
coeliac patients (Sollid et al. 1989). However, about 25% of population carries these genes without 
developing the disease (Sollid et al. 1989) and they cannot therefore be the only genes contributing to 
the development of the disease. The function of HLA molecules is to present gluten antigens to T-cells. 
If the presented gluten antigens are recognized by the gluten-specific T-cells, an immune reaction 
starts,  leading  to  the  production  of  antibodies  and  cytokines.  The  HLA-DQ2  molecules  are  more  
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common in coeliac patients than HLA-DQ8 molecules and the role of HLA-DQ2 molecules in 
presenting gluten peptides to T-cells has been examined in detail in several studies (Johansen et al. 
1996, Costantini et al. 2005, Bergseng et al. 2008). The HLA-DQ2 and HLA-DQ8 molecules present 
different gluten-derived peptides to the T-cells (Mazzarella et al. 2003, Henderson et al. 2007). 
Pathogenesis was described in detail by Koning et al. (2005), and recent advances were reviewed by 
van Heel and West (2006).  
An alternative pathway of coeliac disease to the above-described adaptive immunoreaction is an innate 
reaction to gluten proteins. Innate immunereaction is a rapid reaction that leads to the secretion of 
interleukin  15  and  intraepithelial  lymphocytes  (IELs).  This  pathway also  results  in  the  destruction  of  
the villous structure in the small intestine of people with coeliac disease (reviewed by Jabri et al. 2005). 
Furthermore, gluten-induced coeliac-type autoantibodies have been implicated in the pathogenesis 
(Caja et al. 2011). 
Prevalence 
Coeliac disease is most prevalent in Western countries. People with coeliac disease are estimated to 
comprise about 1% of the European population as well as that in North America (Kagnoff 2007, 
Mustalahti et al. 2010). Coeliac disease is also found in populations in the Middle East, India and North 
Africa (Malekzadeh et al. 2005). However, it appears be a rare disease in Russia and North Asia 
(Kondrashova et al. 2008). The prevalence of the disease appears to be increasing. In the latest studies, 
the estimated prevalence in Finland has been doubled to 2% (Lohi et al. 2007). The increase is 
suspected to be due to environmental factors and not just to a better detection rate, which has also 
increased. This has raised discussion on whether our modern, highly hygienic lifestyle induces 
autoimmune diseases to occur. 
2.2.2   Immunogenic proteins and peptides 
Proteins involved in coeliac disease 
After the immunogenicity of wheat was established, barley, rye and oats were also included among the 
cereals prohibited for coeliac patients. However, the harmfulness of barley and rye prolamins to coeliac 
patients has scarcely been tested, although, since they are so closely related to wheat prolamins, their 
harmfulness has not seriously been questioned. Recently, the possibility of T-cell testing has offered an 
easier way to study specific peptides, and peptides derived from barley and rye prolamins have 
consequently also been tested. Indeed, peptides homologous to the T-cell stimulatory peptides have 
been found in barley, rye and oats (Vader et al. 2003). In addition, barley and rye prolamins have been 
shown in in vitro studies to produce similar levels of interferon-  mRNA in coeliac duodenal tissue to 
wheat prolamins (Bracken et al. 2006).  
Because of the differences between wheat gliadins and glutenins, the immunoactive role of HMW and 
LMW glutenins in coeliac disease has been questioned. Ciclitira et al. (2005a) separated and mixed 
four HMW glutenin subunits and tested their reactivity with T-cells. Altogether, 11 of the 17 tested T-
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cell lines reacted to the mixture of glutenins. Experiments were also carried out in vivo on three coeliac 
patients. They all developed increased levels of IELs and their villous hight/crypt depth ratio decreased 
(Dewar  et  al.  2006).  The  harmfulness  of  the  HMW  subunits  was  also  demonstrated  by  T-cell  
stimulation by van de Wal et al. (1999) and Molberg et al. (2003). Epitopes triggering coeliac disease 
were found in the LMW glutenins of wheat by database searching, and some of these peptides were 
tested to have T-cell stimulatory activity (Koning and Spaenij-Dekking 2005). It is therefore likely that 
all types of wheat prolamins have T-cell stimulatory properties. A closer study of rye prolamins 
revealed that the -type secalin and -type secalins in addition to two low molecular mass 
glycoproteins of 15 000 and 18 000 g/mol from rye exhibited coeliac serum antigenicity (Rocher et al. 
1996). These small glycoproteins are most likely not prolamins, although able to trigger similar 
symptoms. 
The harmfulness of oats has been debated for years. Oats were initially considered harmful, but many 
clinical studies have subsequently shown the suitability of oats for coeliac patients (reviewed in 
Salovaara et al. 2009). However, oats have caused symptoms in some studies, indicating a harmful 
character (Lundin et al. 2003, Arentz-Hansen et al. 2004). It is possible that a subgroup of coeliac 
sufferers exists who cannot tolerate oats.  
Peptides involved in coeliac disease 
Typical immunogenic prolamin peptides contain large amounts of proline and glutamine, and it seems 
that most of them are located in the repetitive domains. Their structure appears to be dominated by 
disordered random-coil formations and -turns (Darewicz et al. 2007), which are suggested to be 
relevant to coeliac disease (Tatham et al. 1990). However, -turns are common in storage proteins 
because of their high proline content, and are also found in parts of the sequence that are not active in 
coeliac  disease.  Therefore,  -turns  cannot  be  the  only  cause  of  the  harmfulness,  although  they  are  a  
seemingly important characteristic of immunogenic peptides. 
Most of the harmful sequences are found in -gliadin, but the harmfulness of other gliadin groups has 
also been confirmed in vivo (Ciclitira et al. 1984b). Difficulties in the identification of harmful peptides 
have resulted in findings that people with coeliac disease react to varying peptides (Vader et al. 2002b). 
Enzymatic digestion and heating appear to increase the T-cell stimulation capacity of the peptides 
(Lundin et al. 1997). Some of the peptides that are found to be active in coeliac disease are presented in 
Table 2. 
It has turned out to be an immense task to identify the dominant peptides causing coeliac disease to 
manifest  itself.  About  ten  years  ago,  a  peptide  of  33  amino  acids  was  found  to  be  very  resistant  to  
degradation and was therefore suggested to be the most important peptide involved in coeliac disease 
(Shan et al. 2002). However, this finding did not explain the overall pathogenesis of coeliac disease, 
and many more peptides triggering T-cell activation have since been found. Despite this, the peptide of 
33 amino acids has often been used as a model immunogenic peptide. The peptide 
(LQLQPFPQPQLPYPQPQLPYPQPQLPYPQPQPF) is commonly shortened to 33mer. It consists of 
repeats with a large amount of proline and glutamine and sequences that have been tested harmful for 
coeliac patients. Although the pathogenesis of coeliac disease is not entirely explained by the presence 
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of 33mer, the inflammatory character of gluten is suggested to be due to the proteolytic resistance of 
gluten peptides (Shan et al. 2005). At least 60 peptides that are similar to 33mer and which may all be 
active in coeliac disease have been identified by in silico protein analysis (Shan et al. 2005). 
Table 2. Some immunogenic peptides found in wheat prolamins. 
Method Peptide Amino acid sequence* Reference 
In vivo -Gliadin 31–43 LGQQQPFPPQQPY Marsh et al. 1995 
-Gliadin 31–49 LGQQQPFPPQQPYPQPQPF Sturgess et al. 1994 
-Gliadin 44–55 PQPQPFPSQQPY Marsh et al. 1995 
-Gliadin 56–75 LQLQPFPQPQLPYPQPQLPY  Fraser et al. 2003 
-Gliadin 206–217 LGQGSFRPSQQN Mantzaris and Jewell 1991 
In vitro -Gliadin 1–30 VRVPVPQLQPQNPSQQQPQEQVP 
LVQQQQF 
De Ritis et al. 1988 
-Gliadin 3–24 VPVPQLQPQNPSQQQPQEQVPL Wieser et al. 1986 
-Gliadin 57–68 QLQPFPQPELPY Arentz-Hansen et al. 2000 
-Gliadin 62–75 PQPELPYPQPQLPY Arentz-Hansen et al. 2000 
-Gliadin 198–222 QYPSGQGSFQPSQQNPQA Van de Wal et al. 1998a 
-Gliadin 203–220 QYPSGQGSFQPSQQNPQA Mazzarella et al. 2003 
-Gliadin QPFPQPQLPY, QPFPQPQQTF Arentz-Hansen et al. 2002 
-Gliadin 60–79 LQPQQPFPQQPQQPYPQQPQ Arentz-Hansen et al. 2002 
LMW glutenin QQQQPPFSQQQQSPFSQQQQ Vader et al. 2002b 
LMW glutenin QQPPFSQQQQQPLPQ Vader et al. 2002b 
HMW glutenin GQQGYYPTSPQQS Van de Wal et al. 1999 
*A= alanine, E = glutamic acid, F = phenylalanine, G = glycine, L = leucine, P = proline, Q = 
glutamine, S = serine, T = threonine, Y= tyrosine 
Since the amino acid content, arrangement of proline residues and specific deamidation by tTG are 
important for T-cell recognition, computational methods can be used to detect harmful sequences with 
reasonable accuracy. A database of known T-cell stimulatory sequences and prolamin epitopes was 
created by O’Brien and Feighery (2008). Information on a total of 101 epitopes has been collected from 
published results.  
23 
 
2.2.3   Modified prolamins 
Proteins are modified to improve their functionality and increase their usage in different applications to 
form and stabilize structures. In addition to traditional baking improvers, gluten proteins are used to 
make biofilms (Olabarrieta et al. 2006, Guillaume et al. 2010), and are reported to be good candidates 
as a clarifying agent of red wine (Marchal et al. 2002). Proteins can be modified by various techniques, 
such as deamidation, transamidation and degradation. All of these modifications also happen naturally 
due to enzymes in cereal seeds. Deamidation of prolamin peptides has been found to be a significant 
part of the pathogenesis of coeliac disease, in which the deamidation is caused by a tTG. This enzyme 
is able to deamidate specific glutamines to glutamic acid residues and, as a consequence, enhances the 
binding of the peptides to HLA-DQ2 and -DQ8 molecules. In certain conditions, the transglutaminase 
enzyme may also crosslink. Crosslinking by microbial enzymes is used to improve protein structures in 
food applications. Crosslinking has also been suggested as a tool to reduce the immunoactivity of 
prolamin peptides.  
2.2.3.1  Heating 
Since the formation of a gluten network has a major role in baking, the changes occurring in gluten 
proteins during heating have been extensively studied. During heating, new disulphide bonds are 
formed and they are reorganized from intramolecular to intermolecular bonds, leading to large 
aggregates with lowered solubility (Schofield et al. 1983). The prolamin subgroups undergo changes 
during the baking process that reduce their extractability. The subgroups that contain high amounts of 
sulphur, such as - and -gliadins, are more susceptible to heat-induced changes compared to those 
with a low sulphur content. -Gliadins have been shown to be more sensitive to heating than -gliadins 
(Lagrain et al. 2005). The extractability of - and -gliadins was observed to be lost after heating wheat 
samples for 1 h at 45–110 °C (Lavelli et al. 1996). The extractability was, however, returned by 
reduction. The solubility of -gliadins, which are low in sulphur, is not affected by heating (Schofield 
et al. 1983, Skerritt and Smith 1985). In addition to an increase in the number of intermolecular 
disulphide bonds during heating, other bonds such as isopeptide bonds are formed between the proteins 
(Rombouts et al. 2011). These bonds are not broken by reduction and consequently further decrease the 
solubility of the proteins.  
2.2.3.2  Enzymatic degradation  
Prolamins are not easily degraded by gastrointestinal enzymes. One reason for this is that they contain 
large amounts of the amino acid proline. Proline is a structurally unique amino acid and causes such 
bends in the peptide chain that only specific enzymes are able to cleave the chain (Simpson 2001). 
Proline has a specific character, as it is able to make -turns in the peptide chain. These turns form a 
tighter helix than in a normal -helix, and enable tighter packing of proteins in the endosperm of seeds. 
However, -turns also hinder the action of hydrolysing enzymes. Consequently, relatively large 
peptides are absorbed from the lumen to the gut mucosa. 
Hydrolysis of the proteins during the processing of food could be one way to reduce or abolish the 
harmfulness of prolamin proteins and thus increase the variety of gluten-free cereal foods. The role of 
24 
 
sourdough lactic acid bacteria in reducing the harmfulness of fermented foods to coeliac sufferers has 
been  examined.  It  has  been  claimed that  the  majority  of  ethanol-soluble  rye  polypeptides  are  almost  
totally hydrolysed by lactic acid bacteria, and no prolamins were recognized after 48 h fermentation of 
rye flour when measured by R5-Western blot analysis (De Angelis et al. 2006). The role of endogenous 
enzymes was not, however, determined in that study. These enzymes are most likely to account for the 
majority of prolamin degradation during fermentation. Similar results were obtained with fermented 
durum wheat with lactic acid bacteria in which the gluten content was reduced by 83% with the help of 
fungal enzymes (Di Cagno 2004). However, after successful hydrolysis of the majority of prolamins, 
considerable levels of gluten (1045 ppm) were still detected. By mixing fermented wheat flour with 
other ingredients, however, it was possible to make sweet breads with 8 ppm of gluten. These breads 
did not cause any serological changes or deterioration in the small bowel of people with coeliac disease 
(Greco et al. 2011). 
Endogenous enzymes have a more important role in prolamin degradation than lactic acid bacteria. 
Lactic acid bacteria are thought to adjust the pH to low levels, which are optimal for the endogenous 
enzymes of cereals to function. Therefore, their role is more in pH adjustment rather than protein 
hydrolysis. The extent of prolamin degradation during sourdough fermentation has been studied by 
Loponen et al. (2004) and Tuukkanen et al. (2005). Prolamins were as efficiently degraded during 
fermentation without starter microorganisms (lactic acid bacteria). The most rapid degradation of 
prolamins occurs in rye (Hartmann et al. 2006, Loponen et al 2011). Glutelins were degraded faster at 
30 °C, and prolamins at 15 °C (Hartmann et al. 2006). Under optimum conditions, at pH 4.5 at 50 °C or 
at pH 6.5 between 50 °C and 60 °C, the synthetic gliadin peptides were degraded into peptides of less 
than 9 amino acids within two hours. Such small peptides are not considered to have T-cell stimulation 
activity (Sollid 2002). Proteases preferred cleavage sites between P-Q, Q-P, P-F, L-P and P-Y. 
Loponen et al. (2007) and Stenman et al. (2009) also demonstrated the efficient degradation of wheat 
prolamins by proteases from germinating cereals. 
In addition to endogenous cereal enzymes, various microbial enzymes have been reported to degrade 
prolamins. Although endogenous enzymes are very efficient in degrading prolamin proteins, levels still 
harmful for coeliacs remain. These remaining prolamins have successfully been degraded by prolyl 
endoprotease of Aspergillus niger (AN-PEP) (Spaenij-Dekking et al. 2006), Sphingomonas capsulata 
(SC-PEP) (Tye-Din et al. 2010) and prolyl oligopeptidase of Flavobacterium meningosepticum (POP) 
(Shan et al. 2004, Marti et al. 2005). AN-PEP was shown to degrade prolamins efficiently in stomach 
conditions, where POP lost its functionality (Mitea et al. 2008a). However, good results have been 
obtained when combining a recombinant cysteine endoprotease from germinating barley (EP-B2) with 
POP (Siegel et al. 2006). AN-PEP is a serine protease that cleaves the peptide chain after proline 
(Edens et al. 2005). It has a pH optimum between 4 and 5 and remains stable at pH 2. It was found to 
be completely resistant to pepsin, which enables its use in the stomach environment, whereas the POP 
enzyme was found to be degraded by pepsin and only be active at a neutral pH. AN-PEP was found to 
efficiently degrade T-cell stimulatory epitopes from intact gluten as well as from digested peptides 
(Stepniak et al. 2006). AN-PEP has also been shown to be very efficient in degrading gluten from 
white bread and in fast food meal to such an extent that no immunoactivity remained. The degradation 
was modelled using a dynamic gastrointestinal model that mimics the human stomach and small 
intestine (Mitea et al. 2008a). Another advantage of AN-PEP (commercially available as Brewers 
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Clarex, DSM, the Netherlands) is that it is food grade and can therefore potentially be used orally as an 
enzyme therapy after ingestion of gluten-containing food as well as endogenous cereal enzymes.  
2.2.3.3  Deamidation  
Deamidation of proteins can be carried out using enzymatic or chemical methods. Enzymatic reactions 
are preferred in food processes, since they are considered safer (Shih 1996). Deamidation means that 
the amide group of glutamine or asparagine is removed and replaced by a hydroxyl group. As a 
consequence, they are changed to glutamic acid and aspartic acid, respectively, and ammonium is 







Figure 3. Deamidation of glutamine to glutamic acid. Deamidation is preferred at low pH values and 
with high relative amounts of glutamine. 
Even limited (2–5%) deamidation may improve the functional properties of the proteins (Shih 1996). 
As the level of deamidation increases, the surface hydrophobicity of the protein increases (Matsudomi 
et al. 1982), consequently increasing the emulsifying potential and emulsion stability (Wu et al. 1976). 
The foam-forming capacity of deamidated gliadin is slightly better than the capacity of egg white 
(MacDonald and Pence 1961).  
The tTG-induced deamidation of prolamin proteins has been shown to considerably increase their 
binding to HLA-DQ2 or -DQ8 molecules (Molberg et al. 1998, Sjöström et al. 1998). As a 
consequence, deamidation increases the T-cell stimulating activity of prolamin peptides (Arentz-
Hansen et al. 2000, Ellis et al. 2003). tTG is a calcium-dependent enzyme that catalyses the 
posttranslational modification of proteins by transamidation and deamidation. The enzyme belongs to 
the  family  of  transglutaminase  enzymes  and  is  also  known as  transglutaminase  2.  It  is  a  cytoplasmic  
enzyme and is found in many cells. The function of the enzyme is not known, but it is involved in 
stabilizing molecules in physiological and pathological processes (Greenberg et al. 1991). It has a role 
in the regulation of the cytoskeleton, cell adhesion and cell death, while a mouse model has shown that 
the enzyme is involved in impaired wound healing, autoimmunity and diabetes (Fesus and Piacentini 
2002). In addition to its important role in the pathogenesis of coeliac disease, tTG is also involved in 
fibrosis, Alzheimer’s disease and Huntington’s disease (Fesus and Piacentini 2002, Jabri et al. 2005). 
People with coeliac disease develop increased levels of autoantibodies against tTG. These antibodies 
are important in diagnosis (Sulkanen et al. 1998, Sblattero et al. 2000, Reif and Lerner 2004), since 
they are found from almost everyone with untreated coeliac disease (Dieterich et al. 1997, 1998). 
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Binding to the human gliadin antibodies found from the sera of patients with coeliac disease is 
enhanced after the deamidation of gliadin peptides, in which tripeptide PEQ has been found to be 
important for antibody binding (Osman et al. 2000). Since similar effects on T-cell stimulation can be 
obtained by the acid deamidation of prolamins and by enzymatic deamidation with transglutaminase, it 
has been speculated that harmful deamidation of gluten peptides could occur in the acid environment in 
the stomach (Sjöström et al. 1998). However, in the studies of Wieser (2005a) and Kahlenberg et al. 
(2005), deamidation was not observed to occur in the acidic conditions of the stomach or in the 
conditions for peptic digestion. However, the results of Kahlenberg et al. (2005) indicated that food 
processing under acidic conditions may reduce the detectability of gluten proteins with antibody assays 
used for detecting the gluten content.  
2.2.3.4  Transamidation  
Transamidation results in crosslinks between lysine (or another amine donor) and the glutamine 
residues of proteins by covalent bonding (Figure 4). Crosslinking is catalyzed by tTG at higher pH 
values and with high lysine concentrations. The covalent isopeptide bond between the protein and 







Figure 4.  Transamidation between glutamine and primary amine donors. 
Microbial transglutaminase (mTG) does not have such a catalysing effect on deamidation as tTG 
(Gianfrani et al. 2007). In cereal food applications, mTG has been used for crosslinking to improve the 
baking qualities of weak wheat flours. The effects of mTG on the structure, cross-linking and 
rheological properties of gluten proteins have been investigated by Bauer et al. (2003a and 2003b). The 
treatment of wheat flour with mTG and lysine methyl ester was an effective inhibitor of intestinal 
gliadin-induced IFN-  production, which suggests the use of amine donors in blocking T-cell acitivity 
in the treatment of coeliac disease (Gianfrani et al. 2007). The addition of mTG to wheat flours was not 
observed to affect quantification using the sandwich R5 antibody, and only a minimal decrease in 





2.3   Analysis of prolamin proteins 
Based on the standard for gluten-free foods, the method to determine gluten should be based on an 
immunological method or other method providing at least equal sensitivity and specificity (Codex 
Standard 118-1979). The antibody should recognize the harmful peptides and should not react with 
other food proteins. The detection limit of the method should be at least 10 mg of gluten / kg of food. 
Although an immunological method is recommended for quantitative gluten analysis, the use of other 
methods is not excluded. Many analytical methods have been used to either qualify or quantify 
prolamins. Prolamins have multiple roles in food manufacturing and are therefore often analysed from 
cereal material for other purposes than simply for their presence in gluten-free products. For example, 
wheat prolamins play an important role in dough quality, and barley prolamins are involved in beer 
haze formation. Prolamins have also been demonstrated to be good for cultivar identification, since 
each cultivar has a unique prolamin composition (Shewry et al. 1978, Jussila et al. 1992, Kubiczek et 
al. 1993, Dvo ek et al. 2003). 
2.3.1 Chemical analysis 
Many methods for detecting prolamin proteins have been developed over the years. The complexity of 
prolamin proteins, however, creates an enormous challenge in accurately quantifying the total prolamin 
content. Some of the methods, including the polymerase chain reaction (PCR), HPLC and MS, are used 
simultaneously  with  immunological  methods.  One  of  the  most  recent  methods  in  gluten  analysis  is  a  
potentiometric electronic tongue, which was able to detect 1–2 mg/kg of gliadin from different food 
matrices (Peres et al. 2011). 
Gel electrophoresis has a long history in protein analysis. Prolamin subgroups were originally 
identified based on their mobility in acid electrophoresis, and SDS-PAGE is used widely to qualify 
prolamin proteins. Currently, the subgroups are also separated by HPLC, which additionally enables 
their quantification (Wieser et al. 1994). The qualification of proteins by SDS-PAGE is further 
improved by adding another dimension that separates the proteins based on their isoelectric points, 
creating  one  form  of  a  2D-PAGE  system.  This  is  very  useful,  since  most  of  the  protein  bands  of  
prolamins separated by SDS-PAGE contain multiple proteins, and an additional dimension enables 
their separation and identification. A relatively new method based on the same separation technique is 
known as lab-on-chip electrophoresis. In this method, the separation gel is in a small capillary in a chip 
and the proteins are detected with fluorescence detection as they pass the detector. The data are 
simultaneously collected with a computer program. This method is much faster to perform than 
traditional gel electrophoresis, since it takes only 30 min for 10 samples to be analysed. However, the 
separation  of  proteins  is  not  as  good,  and  not  as  many  choices  of  gel  material  are  available  as  with  
PAGE. Lab-on-chip electrophoresis has been used to identify wheat varieties based on the differences 
in their HMW and LMW glutenin subunits (Uthayakumaran et al. 2005, Bradová and Matejova 2008), 





Another technique used in prolamin analyses is PCR, which is based on the detection of 
deoxyribonucleic acid (DNA) from the studied species. However, the method does not recognize 
proteins, as the other detection methods do, which causes a major problem. DNA can exist in a sample 
without any proteins being present. For example, the addition of wheat starch can add wheat DNA to 
the product without a significant increase in protein. This situation can be resolved by combining the 
PCR method with immunological analysis (Allmann et al. 1993, Dahinden et al. 2001). DNA is also 
easily destroyed during food processing and might therefore give a negative result, despite harmful 
proteins being present. Mujico and Méndez (2006) observed that results from PCR and prolamin 
contents obtained with the R5 antibody did not correlate in heat-processed samples. However, the PCR 
method appeared more sensitive than immunological ELISA methods when wheat contamination in 
oats was determined (Köppel et al. 1998). Despite its weaknesses in gluten analysis, PCR has been 
extensively used in the analysis of contamination of gluten-free products (Sandberg et al. 2003, 
Olexová et al. 2006) or to identify species and varieties (Terzi et al. 2005). 
2.3.2 Immunological analysis 
Enzyme-linked immunosorbent assays (ELISAs) have become the recommended methods in gluten 
analysis. Immunological methods are based on the antibodies raised against the different prolamin 
fractions or specific sequences found in prolamins. The requirement for the assays is that they should 
measure the harmful proteins and peptides, regardless of the type of food or manufacturing process 
(Denery-Papini et al. 1999). The methods for gluten analysis are summarized in Table 3. 
2.3.2.1  Prolamin-specific antibodies 
Various mono- and polyclonal antibodies have been developed against prolamin proteins. Almost 
without exception, they have been raised against wheat gliadin or its subfractions. In most cases, the 
antibodies raised against one prolamin fraction recognise all the other prolamin fractions (Brett et al. 
1999, Rumbo et al. 2000). Because of the structural homology of prolamins, the antibodies find 
multiple reaction sites from different prolamins. However, reaction intensities differ between the 
subgroups. Despite the development of multiple potential prolamin-specific antibodies, only two of 
them, the -gliadin antibody and the R5 antibody, have gained widespread approval and have been 
used in recommended gluten analysis assays.  
Antibody against -gliadin 
The -gliadin antibody was produced by Skerritt in the late 1980s. It is a monoclonal antibody that was 
raised against wheat gliadin and observed to recognize the heat-stable -fraction of gliadin. The 
antibody mainly recognizes -type prolamins and HMW subunits (Skerritt and Hill 1990, van Eckert et 
al. 2008). The antibody has also been referred to as 401.21. 
Before development of the assay, Skerritt developed multiple antibodies and tested their reactivity 
against prolamins from different cereals. Among other tests, Skerritt and Smith (1985) examined how 
the antibody reacted with prolamins in wheat flour samples mixed with water and heated for different 
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periods of time. They noticed the disappearance of other gliadins apart from -gliadins as the heating 
time increased. The recognition of -gliadins by the antibody was not altered by heating, which made it 
highly suitable for gluten detection in processed foods. The -type prolamins lack cysteine and are 
very low in lysine, which makes them highly resistant to heat. This antibody was a very important 
development at the time, since for the first time the prolamin proteins could also be quantified from 
processed foods.  
However, the antibody has weaknesses. For example, the quantitative analysis is based on the relative 
amount of -gliadins, which varies between cereal species and varieties. As a consequence, the results 
can vary depending on the relative -gliadin content. In addition, the reaction of the antibody to barley 
prolamins is very weak, and only less than 10% of hordeins can be quantified.  
Antibody against pentapeptide QQPFP (R5) 
R5 antibody was raised against an ethanol extract of rye (Sorell et al. 1998). The R5 antibody mainly 
recognizes - and -gliadins, whereas a somewhat weaker response was obtained for -gliadins and 
proteins of over 75 kD (van Eckert et al. 2010). More specific analysis has revealed that the antibody 
mainly recognizes the epitope QQPFP. It is also able to recognize homologous epitopes such as 
LQPFP, QLPYP, QLPTF, QQSFP, QQTFP, PQPFP, QQPYP and PQPFP, although with weaker 
reactivity (Osman et al. 2001). Scanning of the complete sequence of -secalin demonstrated the 
reactivity of R5 against the epitopes QQPFPQ, QQPFPL, PQQPFP, SQQPFP, QLPFPQ, QRPFAQ and 
QQSFPQ (Kahlenberg et al. 2004). QQPFP occurs in the repetitive domains of prolamins and has been 
found to occur multiple times in -type prolamins (Kahlenberg et al. 2004). Therefore, the antibody is 
a very good candidate for the detection of prolamins. ELISA methods based on the R5 antibody are 
currently recommended for gluten analysis in the Codex Alimentarius (Codex Stan 118-1979). 
The R5 antibody has weaknesses. It also recognizes other food proteins, and not only harmful 
prolamins, such as soya and lupin proteins (Immer and Haas-Lauterbach 2005a). However, using a 
cocktail solution (60% ethanol with 2-mercaptoethanol and guanidine hydrochloride) for the soya 
samples instead of ethanol, false positive reactions with antibodies were no longer observable with the 
soya samples (Immer and Haas-Lauterbach 2005a). Mena et al. (2007) found in their study that soya 
proteins were able to create an emulsion in 60% ethanol, and could not be separated from the 
supernatant during centrifugation. When reduction is performed prior to extraction, which is the case 
when  using  the  cocktail  solution,  soya  proteins  were  separated  into  pellets  and  the  emulsion  
disappeared. The antibody also reacts unexpectedly strongly with barley prolamins (Malmheden-Yman 
2006). This characteristic especially jeopardizes the addition of oat products to the selection of gluten-
free products. 
Antibody against 19-mer of A-gliadin (PN3) 
New approach to gluten analysis is to develop antibodies against harmful fragments of prolamins. PN3 
is a monoclonal antibody raised against an epitope of 19 amino acids of A-gliadin (19mer). This 
epitope has been shown to be harmful in vivo (Sturgess et al. 1994). PN3 antibody reacts strongly with 
-  and -gliadins,  but only weakly with -gliadins (van Eckert  et  al.  2010).  The antibody also reacts 
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with LMW glutenins, rye secalins and barley hordeins, but not with HMW glutenins, oat avenins or 
maize zeins. The main recognition epitope is QQQPFP (Ciclitira and Ellis 1999).  
Antibodies against 33-mer (G12 and A1) 
Two antibodies, G12 and A1, have been raised against 33mer. The G12 antibody was developed by 
Morón et al. (2008a) and it especially recognizes the hexapeptide QPQLPY. The antibody is highly 
selective for 33mer and similar peptides found in barley and rye. It also detects similar sequences from 
oats. Another antibody against 33mer, A1, was developed by the same research group. The A1 
antibody recognizes the heptameric sequence QLPYPQP, which is also a part of 33mer. A1 has a 
higher  sensitivity  for  gluten  detection  that  the  G12  antibody;  however,  G12  has  a  better  affinity  for  
33mer (Morón et al. 2008a). 
2.3.2.2  Enzyme-linked immunosorbent assays 
Since the mid-1980s, multiple immunochemical gluten analysis methods have been developed. The 
earlier methods were reviewed by Howdle and Losowsky (1990). Two ELISA formats, sandwich and 
competitive, are widely used in gluten analysis (Figure 5). The sandwich method is based on two 
antibodies. The first is called a coating antibody and the second a detecting antibody. The coating 
antibody is bound to the bottoms of the microplate wells and the detecting antibody is used to detect the 
antigens (proteins of interest) attached to the coating antibody. An enzyme is linked to the detecting 
antibody. Commonly used enzymes include horse radish peroxidase (HRP) and alkaline phosphatase 
(AP). The purpose of the enzyme is to induce a colour reaction involving chromogen, which can be 
measured by spectrophotometric methods. The coating and detecting antibody can be the same 
antibody or they can be different. For the method to work, the sample protein must be large enough for 
two antibodies to attach to it at the same time. Therefore, the sandwich technique is not suitable for 







Figure 5. The sandwich (left) and competitive ELISA (right) systems. Antibodies are in red, antigens 
in blue and enzymes in green. 
The competitive method, on the other hand, is based on the competition between sample proteins and 
standard proteins. Only one antibody is used in this assay, which makes it suitable for also detecting 
small, hydrolysed proteins and peptides. However, the specificity of the method may not be as good as 
that obtained with the sandwich format, since nonspecific binding is more likely when only one binding 
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site is needed for detection. The enzyme in competitive systems can be conjugated with the antibody or 
with the standard peptide/protein. Either way, in the competitive assay format, the intensity of the 
colour reaction is inversely proportional to the amount of antigen in the sample. 
Many ELISA assays, both sandwich and competitive, are commercially available (Table 3). The 
ELISA based on the R5 antibody is currently recommended by the Codex standard, and is therefore 
practically the only method in use. The R5 ELISA method replaced ELISA based on the -gliadin 
antibody,  which  was  recommended  earlier.  These  two  methods  and  also  some  emerging  methods  in  
gluten analysis are described here in more detail.   
-Gliadin ELISA– the Skerritt method  
This method was developed in the 1990s by Skerritt and co-workers. After development and successful 
collaborative testing, the method was approved by the AOAC (Association for Official Analytical 
Chemists), and it was used for many years in gluten analysis. The method is based on an antibody that 
recognizes the heat-stable -gliadin fraction. This is an advantage, since that fraction remains 
unchanged during the processing of food. However, the disadvantage of the method is that the different 
relative contents of the -fraction among cereal species causes considerable variation in the 
quantitative results. Not only different varieties, but also the availability of nitrogen during grain 
development alters the content of the -fraction (Shewry and Tatham 1999). Therefore, fertilization 
may have strong effect on the protein composition of the grain. These changes in protein composition 
affect the immunological analysis results, especially with -specific antibody. The other disadvantage 
is that method has only a weak response to barley hordeins.  
Before developing an ELISA assay, Skerritt developed a ‘disc-in-tube’ method, since the binding of 
gliadin to plastic plates was noted to be low and strongly affected by solvents (Skerritt 1985). 
Nitrocellulose was better in binding gliadin proteins. The discs of nitrocellulose were soaked with the 
gliadin-containing sample and blocked with bovine serum albumine. The gliadins attached to the discs 
were detected by monoclonal anti-gliadin antibody conjugated to horseradish peroxidase. This method 
successfully quantified prolamins from different foods including starch, soya, milk and egg powder, 
raw meats, different soups and baked goods.  
In 1990, Skerritt and Hill published a monoclonal antibody sandwich enzyme immunoassay. The 
method was based on the monoclonal antibody immunoglobulin G1, which recognizes the heat-stable 
-gliadins  and  related  prolamins  of  rye  and  barley.  The  results  of  a  collaborative  study  with  ELISA 
were published in 1991 (Skerritt and Hill 1991). The repeatability of the method was 16–22% and the 
reproducibility 24–33%. The assay was semiquantitative for processed meat products, but quantitative 
for cereal and soup products. No false positive results were obtained. Samples included meat-gluten 
blends, wheat flours, wheat flour cookies, gluten-free baking mixes, maize starch and soup thickened 
with wheat flour (Skerritt and Hill 1991). Prolamins from various types of foods were extracted with 
40% ethanol.  
This method is no longer in general use, since it was replaced by R5 ELISA. However, it can still be 
obtained from Biocontrol Systems, USA, under the name Transia Plate Gluten, from ELISA Systems, 
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Australia,  under  the  name  Gliadin  assay,  from  ELISA  Technologies,  USA,  under  the  name  
GlutenELISA, from Neogen, USA, under the name Tepnel Biokits Gluten Assay Kit and from 
Diagnostics Innovations Ltd., UK, under the name HAVen Gluten Kit.  
R5 ELISA – the Méndez method  
The R5 ELISA method was developed by Méndez and co-workers (Valdés et al. 2003). It quickly 
replaced -gliadin ELISA, since it was able to detect barley hordeins and was not as affected by the 
cultivars as the previous method. The international ring trial of the method was organized by the 
Prolamin Working Group (PWG) during 2002 (Méndez et al. 2005) and involved 20 laboratories and 
two  test  systems  (Ingenasa  and  R-Biopharm).  The  samples  studied  in  the  trial  contained  heated  and  
spiked maize bread samples, unheated spiked rice bread samples and contaminated gluten-free samples. 
The repeatability and reproducibility were found to be 20% and 32% for the Ingenasa kit and 18% and 
30% for the R-Biopharm kit. These values were considered acceptable for immunological analysis.  
The first step in developing the R5 ELISA was an ELISA method that was based on an antibody 
cocktail of three antibodies: Rye3, Rye5 and 13B4 (Sorell et al. 1998). Later on, the group developed 
the  method  further  and  limited  it  to  only  one  single  antibody,  R5  (Valdés  et  al.  2003).  The  cocktail  
extraction procedure is recommended to be used with sandwich R5 ELISA. This means that prolamins 
are reduced before extraction by 2-mercaptoethanol. The extraction is further enhanced by guanidine 
hydrochloride (a disaggregating agent). The cocktail solution was introduced in 2000 at the 15th 
Meeting of the Prolamin Working Group and published in 2005 (García et al. 2005). Later, the group of 
Méndez compared extraction with the cocktail solution to that with aqueous ethanol (García et al. 
2003). The recoveries obtained with the cocktail solution were from 70 to 98%, while the recoveries of 
gluten from the same samples with 60% ethanol were about 30 to 50%.  
Competitive R5 ELISA was introduced at the 18th PWG meeting in 2003 (Ferre et al. 2004). It 
detected prolamins from beer and syrup samples more efficiently than the sandwich method. The 
standards used in the first competitive assay were PWG gliadin digested with pepsin, trypsin, 
pepsin+trypsin, chymotrypsin or with a pool of these enzymes. The results for the beer samples were 
from 1.9 to 17 times higher with competitive R5 than with sandwich R5. However, higher results were 
obtained for breakfast cereals with sandwich method than the competitive method (Hernando et al. 
2005). This was suggested to occur because of heat treatment. Extraction with the cocktail solution is 
not compatible with competitive ELISA (Immer and Haas-Lauterbach 2005b), and heat-treated proteins 
may therefore remain unextracted when ethanol extraction without reduction is used.  
The method is available from BioControl Systems, USA (Transia Plate Prolamins), Ingenasa, Madrid, 
Spain (Ingezim Gluten), Neogen, USA (Veratox for Gliadin R5) and R-Biopharm, Darmstadt, 
Germany (Ridascreen Gliadin and Ridascreen Gliadin Competitive). It should be noted, however, that 
the gliadin standard in the ELISA test of BioControl is from the wheat variety Timgalen, the intensity 
of which is about a half of that of PWG gliadin (Hasselberg et al. 2004). PWG gliadin is used in the 
ELISA by Ingenasa, and the standard of R-Biopharm is calibrated to PWG gliadin. The standards are 




Other immunological ELISA systems based on different antibodies have also been developed. 
McKillop et al. (1985) and Troncone et al. (1986) developed ELISAs based on polyclonal rabbit 
antisera against gliadin with very low detection limits. The assay of McKillop was not tested with 
heated samples and that of Troncone reacted with proteins from rice and maize that are not harmful for 
coeliac patients. Friis (1988) also developed an ELISA using a polyclonal rabbit antibody; however, 
this antibody additionally recognized proteins from buckwheat. Furthermore, the author was concerned 
about the accuracy when detecting prolamins from heated samples. Freedman et al. (1987) developed 
an ELISA based on a monoclonal mouse IgM antibody. This method was promising, since it detected 
all prolamin fractions of wheat and also barley and rye. Unfortunately, the antibody also recognized oat 
proteins. The same problem occurred with the ELISAs developed by Chirdo et al. (1995, 1998). Ellis et 
al. (1998) developed an ELISA based on the PN3 antibody, in which a polyclonal gliadin antibody was 
used as the capture antibody. The sensitivity of the assay was 4 ng/ml for gliadins, 500 ng/ml for 
secalins and 1000 ng/ml for avenins and hordeins. Subsequently, a competitive ELISA was developed 
with the same antibody (Bermudo Redondo et al. 2005). The competitive assay based on the PN3 
detected equally harmful peptides from wheat, barley, rye and oats, and it was claimed to be specific 
for the cereal proteins that cause coeliac disease, and to be capable of detecting hydrolysates. The 
detection limit of the assay was reported to be 0.128 ppm with good reproducibility. Neither of these 
above-mentioned methods are commercially available. The ones that are available are described in 
more detail below. 
ImmunoTech a Beckman Coulter Company (Pardubice, Czech Republic) developed a gliadin ELISA 
kit  based  on  two monoclonal  antibodies  against  two different  epitopes  of  gliadin  and  one  polyclonal  
antibody (Gabrovská et al. 2004, 2006, Sánchez et al. 2007). The detection limit of the assay is 3 ng/ml, 
and  range  of  the  calibration  scale  is  to  320  ng/ml.  It  recognizes  wheat,  rye  and  spelt  with  the  same  
efficiency, but barley with an efficiency of only about 20–30%. It does not cross-react with oat, maize, 
rice or buckwheat proteins. Extraction is carried out with 40% ethanol. The method is based on the 
PWG gliadin standard. However, the method gives considerably higher results than obtained with the 
Ridascreen assay of r-Biopharm (Gabrovská et al. 2003).   
An ELISA method for detecting -gliadins was developed by Koning and co-workers. Initially, the 
research group developed several antibodies against T-cell stimulatory epitopes. The antibodies were 
raised against synthetic peptides that represented T-cell stimulatory epitopes in -gliadin, -gliadin, 
LMW glutenin and HMW glutenin (Spaenij-Dekking et al. 2006, Mitea et al. 2008b). The antibodies 
were very specific to the epitopes they were raised against and were able to detect homologous epitopes 
in other cereals (barley, oats, wheat, rye and triticale). However, as the method was further developed, 
only the -gliadin antibody was selected for inclusion in the final ELISA. Because of this, the results of 
the method are expressed as -gliadin contents, which are difficult to relate to total gluten levels. The 
method is sold by Europroxima (the Netherlands) under the name GlutenTek ELISA. 
Morón et al. (2008b) developed ELISA methods based on antibodies against 33mer. They developed 
two monoclonal antibodies, G12 and A1, which both are highly selective for 33mer. A competitive 
method and two different sandwich methods based on these antibodies are now available. The 
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competitive ELISA is based on the G12 and sandwich methods either on G12-G12 or G12-A1. The 
detection limit for wheat, barley and rye prolamins was under 1 g/ml with the sandwich method and 
0.5 g/ml with the competitive method (Morón et al. 2008b). The methods are sold by Biomedal 

















Type of test Sensitivity2 
(LOD) 
Kit manufacturers Notes Reference 
-Gliadin 





Not tested with other 
cereals  
Windemann et al. 
1982 
Gliadin - - pAb Sandwich 22 ng/ml - Low reactivity with barley and oats 
McKillop et al. 
1985 
Gliadin - - pAb Sandwich 5 ng/ml - Also detects oats, rice and maize 
Troncone et al. 
1986 
Gliadin - - mAb Sandwich 15 ng/ml - Low reactivity with barley, rye and oats 
Freedman et al. 
1987 
Gliadin - - pAb Competitive 13 ng/ml - Also detects buckwheat Friis et al. 1988 








Specific to -gliadins 
and HMW-glutenins 
Skerritt and Hill 
1990 
Gliadin - - pAb Competitive 1 ng/ml - Also suitable for processed foods Chirdo et al. 1995 













Specific to wheat, 
barley and rye; no 
reactivity with oats, 
rice, soy or maize 
Chirdo et al. 1998 






Claimed to detect 
wheat, barley and rye 
equally 
Valdés et al. 2003, 
Ferre et al. 2004 
19mer PN3 QQQPFP mAb Sandwich Competitive 
4 ng/ml 
128 ng/ml - 
Also detects oats; 
lower sensitivity to 
heated foods 
Ellis et al. 1998, 
Bermudo Redondo 










mAb Competitive 12 ng/ml EuroProxima 
Detects T-cell 
stimulatory peptides of 
wheat, barley and rye 
Spaenij-Dekking 
et al. 2004 
 




2 x mAb 





the same sequences as 
anti-gliadin antibodies 
of coeliac sera 
Gabrovská et al. 
2006,  
Sánchez et al. 
2007 
 









Highly specific for 
33mer and similar 
peptides in barley and 
rye 
Morón et al. 2008b 
Gliadin - - pAb Sandwich 0.3 g/ml 
Morinaga Institute of 
Biological Science, 
Inc., Crystal Chem 
Inc. 
Wheat Protein ELISA 
Kit (Gliadin), gives 
results as the quantity 
of wheat protein 
- 
Not indicated - - - Sandwich 5 g/ml Neogen 
Veratox for gliadin for 
the quantification of 
prolamins 
- 
Not indicated - - - Sandwich 0.6 g/ml Romer Labs 
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The standard is a very important part of quantitative analysis and it should represent the sample as 
closely as possible. Although (or because) this is very well known, many different standards are used in 
gluten analysis. Among the many different gliadin preparations, the most common standards are gliadin 
separated from the Australian wheat variety Timgalen, RM8418, Sigma gliadin and PWG gliadin.  
The gliadin fraction separated from the Australian wheat variety Timgalen has been used in -gliadin 
ELISAs produced by R-Biopharm, Neogen and BioControl Systems. It contains wheat prolamins from 
only one wheat variety, as well as reference material 8418, which is separated from Canadian wheat. 
When only one variety is represented in the standard, it does not take into account the differences 
between the varieties, which may cause inaccuracies in the results. Sigma gliadin and PWG gliadin, on 
the other hand, are prepared from several wheat varieties. Sigma gliadin is isolated from 12 different 
German wheat varieties and is therefore more suitable for broader use. It has been used in the ELISA of 
Riedel-de-Häen (van Eckert and Jordan 2003). PWG gliadin, Sigma gliadin, RM8418 and Timgalen 
gliadin have been reported to express very similar patterns in 2D electrophoresis (van Eckert and 
Jordan 2003). PWG gliadin had the highest gliadin content and RM8418 contained more glutenins, 
albumins and globulins, but the differences were not so clear that the behaviour of the standards in 
different analysis assays could be explained.  
PWG gliadin is currently the recommended reference material, and is therefore described here in detail. 
Other names used in the literature for this material are European wheat gliadin and IRMM-480. In this 
thesis, the name PWG gliadin is preferred. In addition to the widely used PWG gliadin, some emerging 
peptide standards are described. 
PWG gliadin 
PWG gliadin was produced in international collaboration by the PWG in 2000. The standard is a 
representative of European wheat varieties, since it was isolated from the 28 most frequently grown 
wheat varieties from three main wheat-producing European countries: France, Germany and Britain. 
The gliadin fraction was isolated from the mixture of the cultivars according to Wieser et al. (1994). A 
flour mixture was first defatted with n-hexane and vacuum-dried. The albumins and globulins were 
removed by 0.4M NaCl and the gliadins were extracted with 60% ethanol. The gliadin extracts were 
concentrated and dialysed by ultrafiltration against 0.01M acetic acid and freeze-dried. The chemical 
characteristics  are  summarized  in  Table  4.  The  final  protein  content  of  the  standard  was  86.4% after  
albumins and globulins were subtracted. The immunochemical reactions of the standard were tested 







Table 4. Characteristics of PWG gliadin (van Eckert 2002, van Eckert et al. 2006) 
Character Value 
Solubility 0.5mg gliadin/200 l 60% ethanol 
Protein content 87.7% (Kjeldahl), 89.4% (Dumas) 
Gliadin content 67.7% 
Gliadin composition 40.4% , 48.7% , 6.2% 12 and 4.7% 5 
Albumin/globulin 3.4% 
Glutenin contents 28.9% 
 
The certification process by the EC Institute for Reference Materials and Measurements (The 
Methodology Institute  of  the  European  Commission,  IRMM) was  started  soon after  the  material  was  
separated from wheat varieties. Considerable effort was put into characterizing the standard in detail to 
obtain the certified reference material status for it. However, the IRMM did not accept this standard as 
a certified reference material due to its high glutenin content, which prevents it from being a pure 
gliadin standard. 
Peptide standards 
Since a pure gliadin standard turned out to be impossible to separate from cereal material, synthetic 
peptide standards are of interest. The composition of synthetic material is always the same and can be 
known in detail, which is not the case with natural prolamin fractions. Chambers et al. (2001) 
successfully used a synthetic multiantigenic peptide mixture as the standard in gluten analysis. The 
competitive R5 ELISA by R-Biopharm is also calibrated with the synthetic peptide QQPFP. However, 
the results obtained using peptide standards are peptide concentrations instead of the desired protein 
concentrations. Since the limits in gluten-free products are based on the total gluten content and not on 
the peptide content, it is very difficult to compare the peptide concentrations with the total gluten 
content of the sample.  
Another type of peptide standard was developed by Gessendorfer et al. (2009), as they created a 
reference material by hydrolysing a mixture of wheat, barley and rye prolamins. The results obtained 
with this type of standard can more easily be related to the total gluten contents. However, the 
hydrolysis of proteins is difficult to optimize so that no differences between batches occur.  
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2.4   Gluten-free diet and products 
2.4.1   Legislation 
The gluten standard and other regulations concerning gluten-free products can be found in the Codex 
Alimentarius (www.codexalimentarius.net). The Codex Alimentarius is a collection of international 
food standards, advisory codes of practice, guidelines and other recommended measures. The Food and 
Agriculture Organization and the World Health Organization established the Codex Alimentarius 
Commission in 1963. The development of the standards is performed in various committees. Three of 
the committees working under the Commission have specific importance with regard to gluten-free 
foods. These are: 1) the Codex Committee on Nutrition and Foods for Special Dietary Uses 
(CCNFSDU), 2) the Codex Committee on Food Labelling and 3) the Codex Committee on Methods of 
Analysis and Sampling. The official reports of the committee meetings are called alinorms. 
The standard for gluten-free products dates from 1979, when the Codex Alimentarius Commission 
adopted the draft standard as a formal Codex text (Codex Stan 118-1979). At that time, no specific 
methods were available for gluten detection, and the maximum gluten level allowed in gluten-free 
products was set according to the nitrogen content of the sample. The total nitrogen content of a gluten-
containing product that has been rendered gluten-free was not allowed to exceed 0.05g nitrogen per 100 
g of food on a dry matter basis. This was, however, misleading, since many food products contain high 
amounts of endogenous proteins, which increase the total nitrogen level. Most of the nitrogen is present 
in proteins, but gluten proteins make up only a proportion of the total protein content of the sample. 
With the methods based on the nitrogen content, gluten proteins cannot be separated from other 
proteins. Food products that were made of non-gluten-containing cereals were then advised to be 
labelled naturally free from gluten and therefore suitable for a gluten-free diet (Codex Alimentarius 
1979). 
During the last 30 years, knowledge and analysis methods have considerably developed. In the 1990s, 
new methods based on the immunological detection of gluten proteins were developed, including 
methods based on antibodies against -gliadin and R5. Because the new methods were able to separate 
gluten proteins from other proteins, revision of the standard became important. New levels for the 
gluten content and new regulations concerning the addition of gluten were subsequently suggested.  
The first draft of the revised standard is from 1996 (Codex Alimentarius 1997). At that time, the 
maximum gluten levels were discussed. Three alternative approaches were considered: zero-tolerance, 
with the lowest possible level in gluten-free products being the same as the lowest possible level that 
can be detected, and one or two different levels for the gluten content. In the two-level model, one level 
was suggested for products that are naturally gluten-free (20 ppm) and the other for products that have 
been rendered gluten-free (200 ppm). In the one-level model, the maximum gluten amount of 200 ppm 
was suggested to cover both food groups. However, the one-level model was not accepted by the 
Committee and development of the standard proceeded with the two levels for gluten-free products. In 
the meeting of CCNFSDU in 2006, the gluten threshold for products rendered gluten-free was lowered 
from 200 ppm to 100 ppm. Oats were also moved from the list of prohibited grains to the list of cereals 
for which use may be determined at the national level. 
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In 2007, the standard was given a new name, the Codex Standard for foods for special dietary use for 
persons intolerant to gluten. At that time, CCNFSDU continued the discussion concerning the 
thresholds for gluten, but also about the labels and the role of oats (Codex Alimentarius 2008). In 2008, 
the new standard was finally released. The key issues described in the standard were that oats were 
considered gluten-free; however, the gluten content of oats should not exceed 20 ppm. There are two 
categories for gluten-free products: gluten-free and products with a low gluten content. Products that 
belong to the gluten-free category are the ones previously labelled as naturally gluten-free, and 
products with a low gluten content are those rendered gluten-free. The gluten content of gluten-free 
products should not exceed 20 ppm, whereas products with a very low gluten content should not 
exceed 100 ppm. The method for the determination of gluten should be “an enzyme-linked 
immunoassay (ELISA) R5 Mendez Method.” The Codex Standard was used as a basis for EU 
regulation (Commission Regulation (EC) No 41/2009) concerning gluten-free foods, which was 
adopted at the beginning of 2009 and has to be fully endorsed by 2012. All members of the European 
Union are therefore obliged to follow this new revised standard concerning the composition and 
labelling of foodstuffs suitable for people intolerant to gluten. 
Other issues relating to the addition of gluten to otherwise gluten-free products have also gained some 
attention in the Codex Commission. The Codex Alimentarius Commission adopted the amendment to 
the General Standard for the labelling of prepackaged foods that foods and ingredients known to cause 
hypersensitivity shall always be declared, including cereals containing gluten; i.e., wheat, rye, barley, 
oats, spelt or their hybridized strains and products of these (Codex Stan 1-1985). In 2001, it was stated 
in the draft standard for wheat protein products including wheat gluten that “wheat gluten of wheat 
protein products should not be used for technical reasons e.g. coating or processing aids for foods 
which are gluten-free by nature” (Codex Alimentarius 2001). It was declared in the Codex Stan 1-1985 
(Section 4.2.2), that if it is not possible to provide information on allergens transferred to the product, 
the  food  should  not  enter  the  market.  Gluten  is  on  the  list  of  allergens.  A permanent  exception  was,  
however, granted for wheat-based glucose syrups including dextrose, wheat-based maltodextrins and 
products thereof (Commission Directive 2007/68/EC). The granting of this exception was based on a 
study by Kaukinen et al. (2008), which demonstrated that the consumption of these products did not 
cause any harmful effects in people with coeliac disease.  
The  genetic  modification  of  foods  has  also  raised  concerns.  There  have  also  been  studies  aiming  to  
transfer wheat genes to naturally gluten-free cereals to improve their baking quality. However, it is 
recommended by Codex that if genes of allergenic sources are transferred, their role in the elicitation of 
coeliac disease should be evaluated. Transfer from commonly allergenic foods should be avoided, 
unless it has been documented that the gene does not code for an allergen.  
2.4.2   Daily amount 
The tolerable daily amount of gluten has raised discussion. A few clinical studies have been carried out 
on different gliadin levels. Catassi et al. (1993) examined the effect of 100–500 mg of gliadin in the 
daily diet and observed some changes in the small intestinal mucosa of coeliac patients, but without 
serological or clinical symptoms. With a 50 mg daily dose a minimal decreasing trend in the villous 
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height / crypt depth ratio was observed, but no serological changes (Catassi et al. 2007). Due to these 
results, they recommended that the gluten intake be kept under 50 mg/day.  
Collin et al. (2004) took a different approach to estimate the safe amount of gluten for coeliacs. They 
measured the gluten content of naturally gluten-free and wheat starch-based gluten-free products and 
calculated the daily intake from the results. About one quarter of the products contained more than 20 
ppm of gluten, but less than 200 ppm. The flour intake was about 80 g per day. Since the patients who 
were on this diet had a good mucosal recovery, the safe threshold was suggested to be set at 100 ppm. 
The data from a study by Espadaler (2006) showed that people with coeliac disease eat between 200 
and 300 g of gluten-free foods each day in Spain. With a gluten content of 200 ppm, this would mean 
about 40 to 60 mg of gluten is ingested each day. However, Gabrovská et al. (2007) reported in their 
study that the average daily intake among Czech coeliac patients was between 1.5 and 5.5 mg of 
gliadin, which is significantly less than if it was assumed that all the gluten-free products would contain 
200 ppm of gluten. Most of the higher values for gluten intake are caused by random dietary mistakes, 
such as unexpectedly high contamination in gluten-free flour mixes. Gibert et al. (2006) calculated that 
a rather large amount of gluten may be consumed daily if the limit is 200 ppm, and they therefore 
recommended that the limit should be lowered to 20 ppm for products naturally gluten-free and 200 
ppm for products rendered gluten-free to ensure recovery. Biagi et al. (2004) observed that even the 
consumption of a very small amount of gluten, such as in a communion wafer, may prevent the mucosa 
from recovering. However, their study included no control to confirm the result. 
Gluten thresholds have been reviewed by Hischenburger et al. (2006) and Akobeng and Thomas 
(2008), and based on studies conducted in the field, they concluded that amounts lower than 10 mg of 
gluten are unlikely to cause significant symptoms in people with coeliac disease. As a comparison, the 
average amount of gluten ingested daily in a gluten-containing diet is about 13 g (Ciclitira et al. 
2005b). 
2.4.3   Compliance 
Compliance with a gluten-free diet is the main problem in the treatment of coeliac disease, and regular 
follow-up is often needed. Poor compliance may be due to ignorance or a lack of knowledge, but the 
varying labelling of gluten-free products also causes misunderstandings. Efforts to overcome the 
problem with labelling have been made by developing gluten-free labelling systems, legislations and 
recommendations obligating most countries to follow the same guidelines (e.g. EU legislation, Codex, 
FDA). Adherence to the diet may also be jeopardized because gluten may be found in unexpected 
sources such as pharmaceuticals, desserts, flavourings, sauces and soups. Gluten is also used in meat 
and fish products as an extender or in protein enrichment. 
It is probably impossible to offer coeliac patients a wide variety of foods totally free from gluten. Trace 
amounts of gluten are found in wheat starches and in naturally gluten-free cereals. Trace amounts of 
gluten may also be found in products that are manufactured in the same facilities as gluten-containing 
products. Therefore, the label ‘may contain wheat’ can be found on many food products. It is, of 
course, important to ensure that coeliac patients remain healthy; however, this has a downside. The 
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variety of foods in a gluten-free diet is dependent on the accepted gluten levels. If zero tolerance is 
preferred, many food products must be excluded from the diet, including wheat starch-containing 
products. The experience gained so far indicates that the industry producing gluten-free products is 
reluctant to use the label ‘very low gluten content’ and, therefore aims to develop gluten-free products  
of under 20 mg of gluten/kg. If this is not reached, it remains to be seen whether the manufacturers will 
choose not to label their products as gluten-free at all. Compliance with the diet is improved when the 
variety of suitable foods is as wide as possible. Most of the coeliac patients in Finland use wheat 
starch-based gluten-free foods, and compliance with the diet has been good, ranging between 85–90% 
(Collin and Kaukinen 2006). This is high compared to the more typical levels of 50–80% (Ciclitira et 
al. 2005b). One factor increasing compliance might be the free use of oat products in a gluten-free diet. 
These increase the variety of products substantially. However, some patients are very sensitive to 
residual gluten or oats. These patients should be treated accordingly, but their sensitivity should not 
restrict the diet of other people with coeliac disease.   
2.4.4   Gluten-free products  
Wheat starch 
Wheat starch has a controversial role in the gluten-free diet. It has been the basis of the gluten-free diet 
in Europe for about 30 years because of its good technological qualities, but is still not recommended in 
the USA. When wheat starch was included in the gluten-free diet, the amount of residual gluten was 
not known. However, it was found that people with coeliac disease recovered on a gluten-free diet 
despite the use of wheat starch.  
In the 1980s, no test was available to determine the gluten content of the samples, so it was decided 
that if the nitrogen content of a starch-containing product remained under 50 mg / 100 grams of food 
(dry weight), the product would be suitable for a gluten-free diet (Codex standard 118-1979 before 
revision). Since 1992, wheat starch has been considered gluten-free if it contains less than 100 ppm of 
gliadin (dry weight). When the wheat starch Sanostar (Kröner-Stärke) was studied in the production 
year 2000 (Kröner 2003), only 50% of the starches contained less than 100 ppm of gliadin.  The next 
year the company was able to optimize production so that all of its starches were below 100 ppm. 
However, year-to-year variation in gliadin contents was found to be inevitable, since the gliadin content 
in wheat starches depends on the production process and the wheat quality. The content is higher in a 
difficult harvest year and with unfavourable wheat quality, and levels above the current limit of 20 ppm 
may occasionally be found (Kasarda et al. 2008). Nevertheless, a standardized production process is in 
place for gluten-free wheat starch that ensures its safety for people with coeliac disease. 
Wheat starch-based gluten-free products in the treatment of coeliac disease have been reported not to 
cause symptoms relating to coeliac disease, and wheat starch-based gluten-free flour products can 
therefore be safely consumed by coeliac patients (Kaukinen et al. 1999, Peräaho et al. 2003). No harm 
was observed when eating wheat-starch containing gluten-free bread for a one-week follow-up period 




Whether beer made from barley can be included in a gluten-free diet is still unclear. With most gluten-
detecting methods, very low levels of coeliac-harmful peptides have been measured in most beers. The 
competitive method based on the R5 antibody detects the prolamin levels in beers. The current 
recommendations for beers in a gluten-free diet are based on this method, even though it is based on 
the peptide standard and no factor to relate the results to the total gluten level has officially been 
provided. Since barley has been used as a raw material, it is evident that some hordeins will end up in 
the final beer. However, most of the hordeins are removed by filtration and only a very small 
proportion of them are left in the beer. The majority of beer peptides are derived from albumins, which 
are water-soluble proteins and not harmful for coeliac patients (Picariello et al. 2007). 
Oat products 
The allowance of oats in a gluten-free diet differs between countries. The Codex standard for food for 
special dietary use for persons intolerant to gluten states that oats may be included in a gluten-free diet 
if their purity from wheat, rye and barley has been checked. The EU Commission has adopted this, and 
oats that are free from contamination are consequently allowed for people with coeliac disease in the 
countries of the EU. Most studies carried out on oats have proven their suitability for coeliac patients 
(Janatuinen et al. 1995, Picarelli et al. 2001, Kilmartin et al. 2003). However, in some published 
studies, some of the patients have developed gastrointestinal symptoms or serological changes typical 
of coeliac disease or even subtotal villous atrophy while on an oat-containing diet (Lundin et al. 2003, 
Arentz-Hansen et al. 2004, Silano et al. 2007a,b). These cases seem to be exceptions, since no harmful 
effect caused by oats have been found in several long-term trials (Janatuinen et al. 2000, Holm et al. 
2006, Kemppainen et al. 2007). It is possible that there is a subgroup of coeliac patients who are 
intolerant of oats, since similarities between some avenin sequences and harmful gliadin sequences 
have been found (Vader et  al.  2003).  The possibility of harmful and unharmful oat varieties has also 
been suggested (Mujico et al. 2011, Comino et al. 2011). It is not, however, wise to prohibit oats from 
the  diet  of  all  coeliac  patients  simply  because  some coeliacs  cannot  tolerate  them.  The  suitability  of  
oats and their use in a gluten-free diet has been reviewed in several publications (Garsed and Scott 
2007, Dickey 2008, Salovaara et al. 2009).  
The  main  problem  with  oats  is  their  contamination  with  wheat  and  barley.  Very  high  contamination  
levels have been measured from gluten-free foods including oat products (Storsrud et al. 2003, 
Hernando et al. 2006 and 2008, Gélinas et al. 2008). However, some of the contamination levels 
reported in these studies indicate such high levels of barley that the samples must have been flour 
mixtures. 
Oats  have  been  a  part  of  the  gluten-free  diet  in  Finland  for  several  years  without  any  cases  of  clear  
symptoms of coeliac disease, i.e. flattening of the small intestinal mucosa. Oats offer a good addition to 
the gluten-free diet. About 86% of coeliac patients in Finland use oats in their diet (Alden 2010). Oats 
have a mild flavour in contrast to many other gluten-free cereals, which makes them more palatable. 
The use of oats, including kilned oats, increases the dietary intake of fibre, vitamin B, iron and 
magnesium in coeliac patients (Kemppainen et al. 2010). In addition, by having oats in a gluten-free 
diet, the overall gluten intake is reduced (Løvik et al. 2009).  
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2.4.5   New developments  
The only treatment currently recommended for coeliac disease is the exclusion of products containing 
wheat, barley and rye from the diet. However, new approaches are being tested to develop novel 
gluten-free products, including genetic removal of the harmful sequences, enzymatic degradation of 
gluten proteins by oral supplements and blocking of the epitopes or parts of the immune system.   
Plant breeding 
Some researchers are aiming to develop new variants of cereals that are no longer harmful for people 
with coeliac disease. If the immunodominant peptide sequences are known, the immune response may 
be modulated and new plants without these sequences may be developed. The aim is to develop new 
varieties from the old ones which lack genes encoding the gluten subgroups that are harmful for coeliac 
patients. Spaenij-Dekking et al. (2005) found that large variation exists in the amount of T-cell-
stimulatory peptides present in wheat. Based on their results from database searches, it would be 
possible to select wheat varieties with low amounts of T-cell-stimulatory sequences. The focus is on 
developing varieties that do not contain any of the harmful sequences without losing the baking 
qualities. Before this is possible, the harmful sequences in gliadins and glutenins as well as 
corresponding sequences in rye and barley have to be exactly known.  
If there was not so much resistance against genetic modification, it could be a potential way to reduce 
the harmfulness of wheat varieties for coeliac patients. To date, genetic modification of wheat has 
focused on improving herbicide or fungal resistance, but also on improving the dough properties and 
baking qualities of wheat.  
Oral supplements and modifiers 
An alternative therapeutic strategy for coeliac disease is inhibition of the abnormal immune response 
(Lundin and Sollid 2003). The immune response can be inhibited with the use of agents that reduce 
intestinal permeability (Watts et al. 2005), that block HLA-DQ2 or -DQ8 (Bergseng et al. 2005, Jüse et 
al. 2010) or that inhibit tTG (Hausch et al. 2003). Another approach is to break down the harmful 
sequences using enzymes such as POP combined with EP-B2 as an oral supplement or as a pre-
treatment for food (Siegel et al. 2006). 
Polymeric binders are able to reduce the immunoactivity of gliadins. Complexing gliadins with binders 
such as poly(hydroxyethylmethacrylate-co-styrene sulphonate) was shown to hinder the digestion of 
gliadin proteins and consequently decrease the amount of immunogenic peptides produced by 
gastroinstestinal enzymes (Pinier et al. 2009). In addition, a decapeptide (QQPQDAVQPF) from durum 
wheat prevented the activation of coeliac peripheral blood lymphocytes by gliadin peptides (Silano et 
al. 2007c). Przemioslo et al. (1995) prevented the harmful effects of gliadin-sensitive T-cell clones by 
pre-incubating them with anti-interferon  antibody.  
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3   AIMS OF THE STUDY 
The overall aim was to study the prolamin compositions of wheat, barley and rye and the suitability of 
immunological analysis methods to determine the prolamin content accurately from various food 
materials. The specific aims were to: 
 improve the quantification of hydrolysed barley hordeins from beer using a barley 
malt standard (I); 
 improve the accuracy in the quantification of barley contamination in oats using a 
barley standard (II); 
 follow degradation of rye prolamins in sourdough systems with prolamin-specific 
R5 antibody (III); 
 optimize the extraction of prolamins from wheat, barley and rye for immunological 
analysis (IV); 




4   MATERIALS AND METHODS 
This section summarizes the materials and methods, which are presented in more detail in the original 
publications (I–V).  
4.1   Materials 
4.1.1 Cereal materials and products 
Raw material 
Barley malt used for the extraction of the malt protein standard (I) was obtained as a ground meal from 
Sinebrychoff (Kerava, Finland). Oat, wheat, barley and rye grains (II, IV) were obtained from Raisio 
plc (Raisio, Finland) and MTT Agrifood Research Finland (Jokioinen, Finland). The germinated and 
native rye grains for sourdoughs (III) were obtained from Laihian Mallas (Laihia, Finland). The vital 
gluten material was provided by Raisio plc (Raisio, Finland) and synthetic peptides were purchased 
from GenScript Corporation (Piscataway, NJ, USA) (V).  
Products 
The selection of beers was provided by Alko Inc. (Finland). Details of the beer samples are 
summarized in Table 5. Three bread samples that were used for the optimization of prolamin extraction 
(IV) included a wheat bread that was a yeast-leavened toast bread (Vaasan arki vehnäpaahto, Vaasan 
Oy, Estonia), a self-made flat barley bread, which was made using barley meal (Sunnuntai, Raisio, 
Finland), water and salt (no yeast added) and a rye loaf bread made using a sourdough process (Uotilan 
Aito Pälkäneen Maalaislimppu, Uotilan leipomo Oy, Finland). The details of meal and bread samples 
are summarized in Table 6.  
4.1.2 Preparation of meal samples 
Dehulling of oat grains 
The oat grains were dehulled using the Nipere impact dehuller (Teuva, Finland). This separates the 
hulls and grains by impacting the grains against the outer walls by centrifugal force. Lighter hulls are 
separated by air from the heavier grains. The dehuller was carefully cleaned after each use to avoid any 
contamination from other cereal grains. On certain occasions, the oat grains were dehulled by hand to 







The  grains  were  milled  with  a  sample  mill  (Koneteollisuus  Oy,  KT-30,  Finland)  (IV), a coffee mill 
(Krups KM75, Celaya, Mexico) (II) or with a Retsch ZM-200 ultracentrifugal mill (Retsch, Haan, 
Germany) (III). Different sieves were used after or during the milling to either separate seed coat parts 
from the ground barley meal (IV) or to obtain meal with a certain particle size (III).   
Table 5. Details of the beer samples. 
Beer Type Malt type Dry extract 
(mass-%) 
Koff Velvet III ale barley 4.90 
Guinness Special Export IVB stout barley 5.92 
Old Engine Oil IVB ale barley and oat 6.54 
Leffe Radieuse IVB ale barley 6.54 
Urho IVA lager barley 4.13 
Legenda IVA lager barley 4.69 
Nokian Vaalea IVA lager barley - 
Singha IVB lager barley 3.62 
Corona Extra III lager barley, rice and maize 4.29 
Sol III lager barley 3.26 
Zhujiang Beer IVA lager barley and rice 3.56 
Bi-Aglut IVA lager buckwheat and maize 4.19 
Weihenstephaner Hefeweissbier IVA wheat beer barley and wheat - 
Franziskaner Hefe-Weissbier IVA wheat beer barley and wheat 4.01 
Franziskaner Weissbier Kristallklar IVA wheat beer barley and wheat 3.81 
Münchner Kindl Weisse IVA wheat beer barley and wheat 3.70 
 
Table 6. The moisture, ash and protein contents of wheat, barley and rye meal and bread samples (IV). 
Meal samples were made of a mixture of ten varieties. 
Sample Moisture %1 Ash %2 Protein %3 
Wheat meal 11.6 1.55 14.5 
Barley meal 11.4 2.24 13.8 
Rye meal 11.3 1.57 11.9 
Wheat toast-bread 29.2 n.d. 12.8 
Barley flat bread 41.2 n.d. 9.7 
Rye sourdough bread 42.9 n.d. 11.2 
1AACC 44-15A, 2AACC 08-02, 3Dumas method (N x 5.7 for wheat and N x 6.25 for barley and rye), n.d. = not determined 
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Sourdough fermentation (III) 
The rye sourdoughs were prepared by mixing 5.0 g of flour with 2.5 ml of tap water and 5 ml of starter 
culture. The chemical controls were prepared by mixing 5.0 g of flour with 7.5 ml of water containing 
0.5% acetic acid and 1.8% lactic acid. The sourdoughs were fermented for 24 h at a temperature 
suitable for each starter organism. Starter organisms included four lactobacilli strains (Lactobacillus 
sakei LS8, Lactobacillus sanfranciscensis DSM20451T, Lactobacillus sanfraciscensis DSM20451, and 
Lactobacillus reuteri TMW1.103). The chemical sourdough controls were incubated for 24 h at 30 °C 
and 37 °C. Sourdoughs were lyophilized for immunological analysis. 
Deamidation of vital gluten (V) 
Vital wheat gluten was deamidated using a modified procedure of Ma et al. (1986). Deamidation was 
started by adding 200 ml of 0.1M HCl to 5 g of the vital gluten. The suspension was heated at 100 °C 
for 2 h. After the treatment, the suspension was neutralised with sodium hydroxide, dialysed against 
distilled water and the contents were lyophilized.  
 
4.2   Protein analyses 
4.2.1   Extraction  
A  modified  Osborne  fractionation  was  used  as  a  basis  of  the  extractions.  However,  after  noting  that  
some of the prolamins may be extracted with water and salt-soluble albumins and globulins, extraction 
with aqueous alcohols only was preferred for the separation of prolamins. In the preparation of the 
hordein standard from barley malt, pre-extraction with water and salt solutions was performed (I), but 
this  was  omitted  in  the  preparation  of  the  hordein  standard  from barley  meal  (II). Modified Osborne 
fractionation was used in study IV when prolamin-detecting antibodies were compared. 
Before the extraction conditions for wheat, barley and rye prolamins were optimized in study IV, 
varying alcoholic solutions with elevated extraction temperatures were used. Hordeins were separated 
from barley malt with 55% 2-propanol at 60 °C (I), but from barley meal with 60% ethanol at 40 °C 
(II). Rye prolamins for a secalin standard were extracted with 50% 1-propanol containing 1% 
dithiothreitol (DTT) at 50 ºC. The cocktail solution and 60% aqueous ethanol were used according to 
the recommendations of the manufacturers for the extraction when the samples were intended for 
ELISA analysis (II, III, V).  Extraction  with  a  SDS buffer  (2% (w/v)  SDS,  10% (v/v)  glycerol,  62.5  
mM tris(hydroxymethyl)aminomethane, 1% (w/v) DTT) was performed for the lyophilized samples 
before electrophoretic analysis (III, IV). Reducing agents such as 2-mercaptoethanol and DTT were 
added to alcoholic solutions to improve the extraction, except when the samples were extracted for 




Because prolamins are already solubilized in beer samples, no further extraction was needed. Instead, 
the protein fraction was purified using desalting gel columns (Sephadex G-25, Amersham Biosciences) 
and dried prior to SDS-PAGE analysis or evaporated down to 8% of the original volume prior to 
ELISA analysis (I). 
4.2.2   Total protein content  
Three methods were used for the quantification of total proteins. Two of them, the Kjeldahl and Dumas 
methods, were based on the detection of total nitrogen in the sample. The protein content of pearled 
barley was quantified by the Kjeldahl method, whereas the protein contents of the extracts were 
quantified using the method of Lowry (Lowry et al. 1951) (II). The Kjeldahl method includes three 
steps: degradation, distillation and titration. During the degradation the nitrogen of the proteins is 
converted to ammonia by sulphuric acid. The released ammonia is separated by distillation and 
quantified by titration with hydrochloric acid. The Lowry method, on the other hand, is based on the 
oxidation of aromatic amino acid residues such as tyrosine and tryptophan by the acids of the assay. A 
bovine -globulin was used as a standard (II, IV, V).  For  the  optimization  of  the  most  efficient  
extraction solution (IV),  the  Dumas  method  (Vario  MAX  CN,  Germany)  was  used  to  determine  the  
protein contents of different extracts using N x 5.7 for wheat and N x 6.25 for barley and rye (AACC 
Method 46-30). Since the cocktail solution contains guanidine hydrochloride, which makes the 
measurement of total nitrogen irrelevant, the Lowry method was used when quantifying the protein 
contents of the samples that were extracted with the cocktail solution.  
4.2.3   Prolamin content by electrophoresis and Western blotting 
SDS-PAGE and Western blotting with prolamin detecting antibodies were used to study beer prolamins 
(I), degraded rye prolamins (III) and different prolamin subgroups (IV).  The  separation  with  SDS-
PAGE was based on a modified Laemmli procedure using 10–20% Tris-HCl gels (BioRad 
Laboratories, USA) (I), isocratic (12%) or gradient (4–12%) Bis-Tris gels (NuPage, Invitrogen, USA) 
(III, IV).  Prolamin  extracts  or  wheat,  barley  and  rye  meals  were  also  analysed  by  an  automated  gel  
electrophoresis system, a lab-on-chip technique (Experion, BioRad Laboratories, USA). Prolamins 
were extracted with 40% 1-propanol at 50 ºC without reducing and separated using Pro260 chips by 
following the instructions of the manufacturer. 
Dried  samples  were  dissolved  in  an  SDS  sample  buffer  to  a  concentration  of  60  mg/ml  (I) or 100 
mg/ml  (III).  The  sample  buffer  contained  2%  (w/v)  sodium  dodecyl  sulphate  (SDS),  10%  (v/v)  
glycerol, 62.5 mM tris(hydroxymethyl)aminomethane, 1% (w/v) DTT, and bromophenol blue, pH 6.8 
(I) or pH 8.5 (III, IV). The electrophoretic separation was carried out using the Bio Rad MiniProtean II 
electrophoresis system (I) or the electrophoresis system of Invitrogen (III, IV). The running conditions 
were 20 mA/gel for 90 min in the BioRad system and 150 V for 70 min in the Invitrogen system. 
After electrophoretic separation, the proteins were transferred to polyvinylidene fluoride membranes 
using a current of 30 V for 60 min (III, IV) (58 V in Study I). The transfer buffer contained 25 mM 
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tris(hydroxymethyl)aminomethane, 192 mM glycine, and 20% (v/v) methanol. After transfer, the 
membrane was blocked with bovine serum albumin. It was then incubated with either a polyclonal anti-
gliadin antibody (I, IV), a monoclonal R5 antibody (III, IV) or a monoclonal -gliadin antibody (IV).  
The polyclonal rabbit anti-gliadin antibody was detected using a goat anti-rabbit antibody conjugated 
with AP. The R5 and -gliadin antibodies were already conjugated with HRP enzyme, which enabled a 
direct colour reaction after antibody incubation. The colour reaction with HRP was obtained using 
tetramethylbenzidine (Promega, USA), whereas the colour reaction with an alkaline phosphatase 
conjugate of anti-rabbit antibody was induced by 5-bromo-4-chloro-3-indolyl phosphate (BCIP) / 
nitroblue tetrazolim (NBT). The colour reaction with AP is based on the dephosphorylation of BCIP, 
which consequently dimerizes. The dimer reduces NBT to form an insoluble dark blue diformazan 
precipitate, which becomes visible on the membrane. Tetramethylbenzidine, on the other hand, forms a 
blue colour when oxidized by HRP in the presence of an oxidizing agent of hydrogen (or urea) 
peroxide.  
4.2.4   Prolamin content measured by ELISA 
Five different ELISA assays were used in the studies included in this thesis: 1) a sandwich assay based 
on the -gliadin antibody (I, II),  2)  a  sandwich  assay  based  on  the  R5  antibody  (II, III, V),  3)  a  
sandwich assay based on a combination of A1-G12 antibodies (V), 4) a competitive assay based on the 
R5 antibody (III, V), and 5) a competitive method based on the G12 antibody (V). 
The extraction of the samples is described in section 4.2.1.  
Unless otherwise mentioned, two different dilutions were prepared in duplicate for each sample. The 
results with sandwich ELISA were multiplied by two to obtain the total gluten content, except with the 
rye samples (III), since the majority of rye sourdough proteins are considered to be soluble and, 
therefore, present in the sample solution.   
4.2.5   Immunoprecipitation of prolamins 
Immunoprecipitation was used to study more closely the peptides degraded in sourdough systems, 
since ELISA methods cannot distinguish prolamins from each other or indicate the size of the detected 
prolamins. The qualitative detection of prolamins by immunoprecipitation is based on their specific 
separation from the extraction solution by complexing them with an antibody. The antigen-antibody 
complexes are incubated with silicon particles coated with protein G, which reacts with the complexes 
by binding them to the surface of particles. Bound antigen-antibody complexes can be removed from 
the particles and analysed further.  
The residual proteins were extracted from wheat, barley and rye samples after acid-incubations with 
60% ethanol, for 30 min at room temperature (RT), following the recommended extraction of the 
competitive R5 ELISA (R-Biopharm, Germany). Immunoprecipitation was carried out by incubating 
the sample extract with HRP-conjugated R5 antibody for 60 min at RT. After incubation with the 
antibody, Sepharose material (6511-5, Biovision Research, USA) was added to the solution and 
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incubated with antigen-antibody complexes for 30 min at RT. Sample proteins were separated from 
Sepharose by concentrated Laemmli buffer (0.0625M Tris-HCl, pH 8.5, 10% glycerol, 2% SDS, 
bromophenol blue and 2% 2-mercaptoethanol) and boiling for 2–4 min. The separated proteins were 
analysed by SDS-PAGE using 4–12% Bis-Tris gel (NP0323, Invitrogen, USA). The gel was stained 
with Coomassie Brilliant Blue. 
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5   RESULTS 
5.1   Determination of barley prolamins in beers (I) 
We developed a new standard by extracting hordeins from barley malt to quantify barley prolamins 
from lager beers. At the time of present study, only an ELISA method based on the -gliadin antibody 
was available. The antibody had a very low reactivity with barley prolamins, and only less than 10% of 
hordeins could be quantified with the commercially available methods. Unfortunately, obtaining stable 
standard curves was relatively difficult, leading to inconsistent results. The -gliadin antibody was not 
able to recognise barley hordeins at the same concentrations as wheat gliadins (Figure 6). However, 
when approximately 12 times higher concentrations of hordeins were used, a similar standard curve to 
that with gliadin was obtained. This demonstrates that the method can be used in quantifying hordeins, 










Figure 6. Comparison of hordein and gliadin standard curves in a sandwich -gliadin ELISA. 
The standard made of barley malt was used in the -gliadin ELISA for the quantitative analysis of 
hordein contents in various lager beers (Figure 7). Dark ale-type beers contained significantly more 
hordeins than clear lager beers. All of the beers that were studied contained less than 20 ppm prolamins 
and could therefore be categorised as gluten-free. The prolamin contents of selected wheat beers were 
also analysed using a gliadin standard in the assay. They contained about 1000 times more prolamins 

















Figure 7. Hordein levels in different lager beers when a standard made of barley malt was used in a 









Figure 8. Prolamin contents of the wheat beers by a sandwich -gliadin ELISA. Error bars indicate the 
standard deviation of the mean of three repeats. 
The  hordein  compositions  of  selected  beer  samples  were  studied  with  SDS-PAGE  (I: Figure 1). 
Western blotting analysis with a polyclonal anti-gliadin antibody showed that some barley prolamins 
remained. Most of them were from 38 000 to 40 000 g/mol in size (I: Figure 2,3). For one wheat beer 
sample  that  was  included  in  the  study,  gliadins  reacted  much  more  strongly  with  the  antibody  than  
hordeins. Neither distinct separation nor identification of the wheat proteins could be made.  
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5.2   Determination of barley prolamins in oats (II) 
We prepared contaminated oat samples by mixing barley meal with oat meal. Oat meal was milled 
from oat grains that were carefully checked for contamination. The R5 antibody overreacted 
substantially in the presence of barley prolamins when the samples were analysed with the sandwich 
R5 ELISA. The gluten levels obtained with the R5 ELISA were much higher than the levels calculated 
on the basis of the protein content in the barley meal. By preparing our own reference material by 
extracting hordeins from pearled barley, we were able to develop a new standard curve (Figure 9). The 
linear area of the hordein standard curve was obtained at lower concentrations than the linear area of 
the gliadin standard, which explains the higher results for the samples containing barley. The detected 










Figure 9. Comparison of the standard curves for hordein and secalin with the gliadin standard curve of 
the sandwich R5 ELISA.  
Due  to  the  different  reactivity  of  hordeins  and  gliadins  with  the  R5 antibody,  we  tested  how the  R5 
antibody reacts with secalins and whether gluten contents in samples containing rye as a contaminant 
would be as high as with barley (Figure 9). Secalins were observed to behave in a very similar manner 
to the gliadin standard of the assay. Therefore, there is no need for a specific standard for samples 
containing rye.  
We also tested whether the analysis results were higher because the prolamin-detecting antibodies 
recognize oat prolamins (Figure 10). As expected, the polyclonal anti-gliadin antibody reacted strongly 
with avenins, which is explained by the polyclonal character of the antibody. The -gliadin and the R5 
antibodies recognized avenins in the SDS and 60% ethanol extracts. A very low recognition of avenin 
was seen in the cocktail extract. As the protein contents were not set to the same level before 
electrophoretic analysis, due to the extraction protocols four times more proteins were present in the 
60%  ethanol  extract  than  in  the  cocktail  extract.  Both  of  the  monoclonal  antibodies  were  able  to  
recognise oat avenins. However, since the recognition was relatively weak, it does not by itself explain 

























Figure 10. Sodium dodecyl sulphate-polyacryl amide gel electrophoresis (SDS-PAGE) and Western 
blot analysis of wheat and oat samples. Samples 1–3 were wheat samples extracted with the SDS buffer 
(1), 60% v/v ethanol (2) and the cocktail solution (3). Samples 4–7 were oat samples extracted with the 
SDS buffer (4), 60% v/v ethanol (5) and the cocktail solution (6–7). M is a molecular mass marker. A 
polyclonal rabbit anti-gliadin antibody, a monoclonal -gliadin antibody and a monoclonal R5 
antibody  were  used  in  immunodetection.  The  SDS-PAGE  gel  was  stained  with  Coomassie  Brilliant  
Blue R-250. 
5.3   Determination of hydrolysed rye prolamins (III) 
We studied the extensity of hydrolysis of rye prolamins in different sourdough systems. Native rye 
meal and germinated rye meal were used to assess the effect of increasing amounts of endogenous 
enzymes. Four different starter organisms were used in combination with chemical controls. The pH 
decreased during sourdough fermentation from 6.2 (sourdough prepared from native rye meal) and 5.6 
(sourdough prepared from germinated rye meal) to pH 3.7. The chemical sourdoughs had a constant pH 
ranging from 3.4 to 3.6. The sourdough samples were studied by Western blotting with the R5 
antibody, and by the sandwich and competitive R5 tests.   
In Western blotting analysis, the R5 antibody detected all the major secalins from unfermented rye 
meal (III: Figure 7). The fermentation of native rye meals modified the secalin bands by distributing 
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them into several bands, and smaller protein bands appeared. The analysis demonstrated extensive 
prolamin hydrolysis in the sourdough fermentation of germinated rye. All of the major secalin groups 
disappeared, leaving only a faint protein band of about 70 000 g/mol (III: Figure 7). 
The sandwich and competitive R5 ELISA tests were used to quantify the residual prolamins in 
sourdough samples. The results indicated that the prolamins were hydrolysed very efficiently in 
sourdough systems with lactic acid bacteria fermentation, but also in chemical controls. In sourdoughs 
made of germinated rye meal, more than 99.5% of the original rye prolamins were hydrolyzed. The 
prolamin concentrations ranged from 240 to 480 ppm when determined by sandwich R5 ELISA and 
from 280 to 430 ppm with competitive R5 ELISA (III: Table 1). 
The residual proteins after hydrolysis in acidic conditions were further analysed using 
immunoprecipitation with the R5 antibody. In addition to rye sample,  wheat and barley malt  samples 
were included. SDS-PAGE separation was performed for the samples before and after 
immunoprecipitation (Figure 11). It was observed from the gel that the prolamins had been degraded 
and proteins with smaller molecular weights had appeared. The R5 antibody was able to recognise 
residual wheat and rye prolamins of about 20 000–40 000 g/mol in size. Considerably more prolamins 
were recognised in the barley extract. Their mass range was about 20 000–60 000 g/mol; however, low 













Figure 11. Sodium dodecyl sulphate-polyacryl amide gel electrophoretic (SDS-PAGE) separation 
before (extract) and after immunoprecipitation (IP) of residual prolamins of wheat, barley and rye 
degraded in acidic conditions. The protein bands of the antibody R5 are visible in the lane after the 
molecular mass standard.  
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5.4   Optimizing the extraction (IV)  
The optimal conditions for the extraction of prolamins were investigated by comparing different 
concentrations of aqueous ethanol, 1-propanol and 2-propanol, out of which 40% 1-propanol was 
determined to be the most efficient. The effect of temperature during extraction was tested by 
performing the extraction at RT (21 ºC), 50 ºC or at 60 ºC (Figure 12). Heating the samples above RT 
significantly increased the extractability; however, no significant difference was observed between 
50 ºC and 60 ºC. The use of DTT during extraction increased the amount of extractable prolamins 
(Figure 12, IV: Figure 1). Higher concentrations of DTT increased the yield, but were considered 
incompatible with immunological analysis. An extraction solution containing 1% of DTT was observed 
to be sufficient.        
The extraction efficiency of 40% 1-propanol with 1% DTT was compared with the efficiency of 
extraction with the cocktail solution (Figure 13, IV: Table 2). No significant differences were detected 














Figure 12. Extracted prolamin content of barley, rye and wheat at RT and 50 ºC with different levels of 
dithiothreitol. The samples were extracted with a 1:10 ratio of 40% 1-propanol for 20 min. Error bars 















Figure 13. Prolamin contents of wheat, barley and rye meals and bread extracted using 40% 1-
propanol with 1% dithiothreitol (gray) or with the cocktail solution (black). Protein contents were 
analysed by the Lowry method. Error bars indicate the standard deviation of the mean of three repeats. 
Gel electrophoresis of the Osborne fractions of wheat, barley and rye showed that a large number of 
wheat prolamins required reduction before becoming soluble (IV: Figure 3). However, all of the 
prolamin groups of wheat, including a proportion of the HMW glutenin subunits, were present in the 
alcohol  extract,  even  without  reduction.  The  C-hordeins  and  a  proportion  of  the  B-hordeins  were  
dissolved in aqueous 1-propanol without reduction, whereas the remaining polymeric B-hordeins and 
D-hordeins required reduction or even SDS buffer before solubilization. Rye prolamins were mainly 
extracted with aqueous 1-propanol without reduction, although more of the -75 and HMW secalins 
were extracted after reduction.  
The prolamin fractions of wheat, barley and rye were also characterized with a lab-on-chip technique. 
Unique electrophoregrams were obtained for each cereal, which enabled their distinction from one 
another; however, the peaks migrated at the same molecular weights (Figure 14). Therefore, this 
technique cannot be used to identify cereals from a mixture. The protein patterns were clearly different 
















Figure 14. Electrophoregrams of wheat, barley and rye prolamins produced by an automated 
electrophoresis system. The protein patterns were compared with SDS-PAGE separation (blue lane 
upper right corner). Samples were from sequential extraction and extracted with 40% 1-propanol at 
50 ºC without reducing.  
We characterized the affinities of prolamin-specific antibodies that are used in gluten analysis against 
the prolamin groups that were soluble in 40% 1-propanol (VI: Figure 3). The polyclonal anti-gliadin 
antibody recognized all of the prolamin groups of wheat, barley and rye and some of the water and salt 
soluble proteins. The -gliadin antibody strongly detected -gliadins and HMW glutenin subunits, 
HMW and -75 secalins, and C- and D-hordeins, whereas a weak response was obtained with B-
hordeins and -secalins. The R5 antibody reacted strongly with -, -gliadins and LMW glutenins, 
with all of the secalin fractions, and with B-hordeins.  It also recognized -gliadins and HMW glutenin 
subunits  and  C-hordeins,  but  less  intensively.  In  addition,  the  antibody  R5  reacted  with  some  of  the  
water and salt-soluble proteins of wheat and rye. 
5.5   Determination of deamidated gluten (V) 
The competitive ELISA methods based on the antibodies R5 and G12 recognized the synthetic peptides 
with varying intensities, whereas neither of the tested sandwich ELISA methods were able to recognize 
them. The concentration of the peptides ranged from 24% to 50% when quantified by competitive R5 
ELISA  and  compared  with  the  original  amount  of  the  peptide  weighed  into  the  sample  solution  (V: 
Table 2). The G12 antibody only recognized the peptide with 33 amino acids, which it was originally 
raised against. The ability of antibodies to recognize the deamidated peptides was considerably 
decreased. The relative intensity obtained for the peptides, which modelled tranglutaminase 
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deamidation, was only 4–8% compared to the intensity obtained for the intact peptides (V: Figure 1). 
The random deamidation reduced the intensities down to the level of 13–54% from the intensity of the 
intact peptide.  
In addition to the peptides, native and acid-deamidated gluten proteins were analysed by the ELISA 
methods. The ELISA methods based on -gliadin and A1-G12 failed to recognize the deamidated 
gluten,  whereas  their  response  to  the  vital  gluten  was  as  expected  (V: Figure 2). The sandwich and 
competitive R5 ELISA methods also failed to recognize deamidated gluten in the same concentrations 
as  with  the  vital  gluten  (Figure  15).  However,  when  the  protein  content  of  samples  containing  
deamidated gluten was increased approximately 600 times, they were measurable with sandwich R5 
ELISA  (V: Figure 3). Competitive R5 ELISA needed about 125 times higher protein contents for 












Figure 15. Comparative reactivity of a vital and deamidated gluten by sandwich R5 ELISA. 
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6   DISCUSSION 
6.1   Prolamins in beers 
At the time of starting this thesis, the main obstacle to barley prolamin analysis was that they could not 
be detected with the recommended gluten analysis assay ( -gliadin ELISA by Skerritt). Only about 4–
8% of barley prolamins could be detected with antibody directed against the -gliadin fraction of 
wheat, and quantitative results for hordeins could not be obtained. Our aim was to develop a better 
standard for barley prolamins that could more accurately measure the hordein content even at low 
levels. Unfortunately, this was not very simple, including problems in getting stable standard curves. 
The discrepancy of the results could be due to the inconsistent reactivity of -gliadin antibody with 
hordeins. Nevertheless, an approximately twelve times higher concentration of hordeins was needed to 
obtain the same absorbances as for gliadins. At the same time, Malmheden Yman and Kruse (2005) 
extracted barley hordein to prepare a hordein standard for beer analysis. They separated hordein from 
barley flours instead of barley malt, as in our studies. They used the standard with ELISA based on -
gliadin antibody and noted that their results were in accordance with those obtained with competitive 
R5 ELISA. At that time, competitive R5 ELISA was under development and was only available to 
those people involved with the PWG. However, their results, together with our findings, support the 
use of hordein standard for samples containing barley. Since beer does not contain similar proteins to 
those of native barley, a barley malt standard could, in our opinion, offer better standard material to 
quantify prolamins in beer. Differences between malts may, however, cause differences between malt 
standards. 
With the SDS-PAGE analysis combined with Western blotting, we noticed the presence of hordeins in 
lager beers. The protein content of beer is about 5–7 g/l (Gorinstein et al. 1999). These proteins are 
mostly polypeptides that have originated from degraded barley proteins. Beer polypeptides, especially 
those with a high proline content, i.e. hordeins, contribute to the haze formation and foam stabilization 
of beer (Siebert 1999). The level of hordeins decreases considerably during the process, and only 
0.11% of the original hordeins have been determined to end up in the final beer (Dostálek et al. 2006). 
This resembles the hordein levels measured in our beer samples. Most of the hordeins are precipitated 
in the brewer’s spent grain, and only minor amounts end up in the final beer. Aggregated B- and D-
hordeins hydrolyse during malting into smaller fragments, which increases their solubility (Celus et al. 
2006). We noticed some proteins left mainly in the same molecular weight area as B-hordeins, 
although they have been shown to be completely hydrolysed by the end of brewing in a previous study 
by Sheehan and Skerritt (1997). However, protein Z also has a similar molecular weight of 40 000 
g/mol. Protein Z is a major protein in beer and contains glutamine-rich repetitive sequences that 
resemble the prolamin storage proteins of wheat (Ostergaard et al. 2000). Consequently, there is a 
possibility that protein Z is detected by prolamin-specific antibodies, although it does not belong to the 
group of proteins that are harmful to people with coeliac disease. Wheat beers, on the other hand, 
contained high levels of prolamins, which clearly excludes their use in a gluten-free diet. It seems that 
wheat prolamins become easily soluble after hydrolysis, whereas barley prolamins tend to precipitate.  
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Although, the usage of a barley standard improved the detection of hordeins by the ELISA method, it is 
likely that sandwich ELISAs are unable to detect all of the hordein residues from beer, apparently due 
to the lack of multiple binding sites on hydrolysed peptides. The gluten levels have been noted to be 
considerably smaller with the sandwich than with the competitive methods (Dostálek et al. 2006). The 
gluten levels determined from the beers were relatively small; however, we were unable to compare 
them with a competitive method. The competitive R5 ELISA is currently used for the detection of 
barley prolamins in beers. However, the method has not been tested by international ring trials, which 
would be important before the method could be taken in wider use. Moreover, the method in its present 
form gives the results in peptide concentrations, and conversion to the gluten level is only an estimate. 
New  methods  based  on  the  detection  of  harmful  peptides,  such  as  33mer  and  other  sequences  in  -
gliadin, have entered the market (Spaenij-Dekking et al. 2004, Morón et al. 2008b). These methods 
could be suitable to detect hordeins from beers. It can be questioned, however, whether all harmful 
peptides are detected with these methods. The antibodies used in the assays have high specificities for 
certain sequences, and some of the harmful peptides may therefore go undetected. Furthermore, the 
suitability of the methods has not yet been tested with beer samples.  
Another approach to improve the gluten analysis of beers is the development of standards that would 
match the hydrolysed sample proteins better than the native gliadin standards. Our attempt to create a 
barley malt standard was a step towards that. Gessendorfer et al. (2009) had a similar approach and 
developed a new reference material by enzymatically hydrolysing prolamins from wheat, rye, and 
barley. Although, their approach was similar to ours, their reference material contained prolamins from 
all harmful cereals. A reference material consisting of hydrolysed prolamins could be more suitable for 
the immunochemical quantitation of similarily hydrolysed prolamins in beer and syrups than standard 
containing native proteins. However, differences in the degree of hydrolysis affect the affinity of 
antibodies. This problem might be resolved by using the same controlled hydrolysis for sample proteins 
as has been used for standard proteins before the analysis. Nevertheless, thorough testing and validation 
is needed before any new reference material can be used in ELISAs. Currently, the hydrolysed 
reference material of Gessendorfer et al. (2009) is being tested in the competitive R5 ELISA, and if 
shown suitable, it could solve the problems in detecting gluten in beers. The new standard could also 
provide more consistent results for different batches of beers, which has been a major problem to date. 
The inconsistency of the results has unnecessarily reduced the number of beers with a gluten-free label, 
since manufacturers do not want to take a risk of one batch being over the limit of 20 ppm of gluten, 
which has been set in the Codex Alimentarius for gluten-free products. 
6.2   Barley contamination in oats 
When oats were allowed for people with coeliac disease, concern was raised about potential 
contamination by harmful cereals. Oats, as well as other gluten-free cereals, can easily be contaminated 
during cultivation, storage, milling, transportation or processing of food. When oat products have been 
studied, unexpectedly high levels of contamination have been found (Gélinas et al. 2008, Hernando et 
al. 2008). Of the analysed oat samples, only 10% contained less than 3 ppm of gluten, 10% between 
45–200 ppm and 80% between 200–8000 ppm (Hernando et al. 2006). These high results were 
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obtained  with  sandwich  ELISA  based  on  the  R5  antibody.  This  antibody  is  able  to  detect  barley  
prolamins, which is a significant improvement over the -gliadin antibody. However, the 
contamination levels in oats of up to 15 000 ppm (Mujico et al. 2005) raised doubts over whether the 
reported values were accurate. These levels would mean the presence of about 20% of barley flour in 
the tested sample. 
We demonstrated that the R5 antibody overreacts with oat samples contaminated with barley meal, 
causing unrealistic results when measuring gluten levels. We prepared contaminated oat samples by 
mixing barley meal with oat meal that was milled from oat grains that were carefully checked to ensure 
the absence of foreign grains. The gluten levels obtained with R5 ELISA were considerably higher than 
the levels calculated on the basis of the protein content of barley meal. Because of these results, we 
were back in the situation where barley prolamins could not be accurately measured by gluten analysis 
assays. We decided to use the same approach as with beer samples, and prepared our own reference 
material by extracting hordeins from pearled barley. We developed a standard curve with this hordein 
standard and analyzed the samples again using this new curve. The detected hordein levels were now 
very close to the expected values. This supported the view that the standard should very closely 
resemble the analyte in order to obtain reliable results. Unfortunately, in practice this might be 
impossible. Commercial gluten-free samples can contain any of the harmful cereals and very often 
contain a combination of them (Mujico et al. 2005). Because of this, it would be impossible to choose 
the appropriate standard for each material. Instead, some sort of combination standard could be more 
accurate.  
Another possible explanation for the high gluten contents recorded in oat samples contaminated by 
barley is that they could be caused by oat prolamins. Western blot analysis of oat samples with the R5 
and the -gliadin antibodies revealed that both of the antibodies were able to recognize oat prolamins. 
This was also confirmed by Comino et al. (2011). It was questioned whether prolamin-specific 
antibodies react with oat prolamins, increasing the response. However, the response was very weak 
compared to the antibody reaction with wheat prolamins, and it had only a minor contribution to the 
determination of the total prolamin.  
6.3   Hydrolysis of prolamins in sourdoughs 
In Finland and in many parts of Eastern Europe, rye products constitute a considerable part of the diet. 
Rye bread is often one of the products that people who have been diagnosed in adulthood with coeliac 
disease long for. A gluten-free diet is often deficient in minerals and dietary fibre due to the high levels 
of gluten-free starch used in the products. Many of the gluten-free cereals or pseudocereals could add 
to the nutritive value, but unfortunately they often have an unappealing taste. Rye, on the other hand, 
would be a good source of fibre and minerals and have a desirable flavour if it did not contain proteins 
harmful to people with coeliac disease. Rye could be used as part of gluten-free baking if the harmful 
proteins were hydrolyzed to such low levels that they would have no remaining immunoactivity. 
Although extensive prolamin hydrolysis has also been observed with wheat prolamins (DiCagno et al. 
2004, Loponen et al. 2007, Rizello et al. 2007), rye prolamins are the ones that seem to be the most 
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efficiently hydrolysed during fermentation (Loponen et al. 2011). This characteristic offers a possibility 
to use rye in gluten-free products to produce the desired taste and flavour. Another characteristic that 
favours rye over wheat is that rye prolamins do not have such an important role as wheat prolamins in 
structure formation during baking. Rye prolamins are not able to form a gluten network similarly to 
wheat prolamins; therefore, hydrolysis of rye prolamins does not affect the baking qualities of rye. In 
wheat, a similar situation would destroy the baking qualities by hydrolysing the gluten network, and 
therefore prohibit wheat baking. The structure formation in rye baking is mainly based on pentosans, 
mostly arabinoxylans, and their ability to bind water and retain gas. The amount of soluble 
arabinoxylans increases in rye sourdoughs due to cereal hemicellulases (Boskov Hansen et al. 2002). 
Because of this, rye sourdough could potentially be used in gluten-free baking processes, which are 
often based on structure-forming carbohydrate polymers.  
We were able to reduce the prolamin content of rye meals by 99.5% from the original level under 
sourdough conditions by using endogenous rye enzymes. Cereal grains naturally contain several 
enzymes that hydrolyze proteins. They are important for the grain to develop and eventually germinate. 
The  main  function  of  prolamins  is  to  store  nitrogen  and  carbon  for  germination;  therefore,  it  can  be  
expected that grain contains endogenous tools to break down these proteins to provide material for the 
seedling to grow. Resting grain contains some aspartic proteinases and carboxypeptidases, but when 
germination starts the amount and number of enzymes increases significantly. The main proteolytic 
activity of germinating rye grain is due to aspartic and cysteine proteinases (Brijs et al. 2002), but 
carboxypeptidases and serine and metallo proteinases also have an important role in the process. 
Therefore, we used germinated rye in sourdough systems to enhance the degradation of rye prolamins. 
However, even after extensive hydrolysis, the prolamin levels still exceeded the maximum levels for 
gluten-free products and could not be considered safe as such. It is, nevertheless, possible to use small 
amounts of sourdough in gluten-free baking. We added rye sourdough to gluten-free oat flour and a 
brownish color and rye flavour appeared in the bread, improving its quality.  
The prolamin contents of the sourdough samples were determined with the sandwich and competitive 
R5 ELISA methods. The results obtained by the sandwich method were not multiplied by two and the 
results obtained with the competitive method were divided by 250, as advised by the manufacturer of 
the assay, to obtain the prolamin content. Since most of rye prolamins are soluble in aqueous alcohols 
and the sourdough process further increases their solubility, it can be assumed that the majority of rye 
prolamins are in the sample solution after extraction and are detected. Furthermore, the results of study 
IV (Figure 3) demonstrate that the R5 antibody was able to recognize all the secalin subgroups. 
Therefore, there was no need to multiply the secalin concentrations and the prolamin concentration of 
sourdoughs was equal to the total gluten content. Although the rye prolamins were successfully 
degraded to very low levels in sourdough systems, some of the prolamins remained and were detected 
by the R5 antibody. The experiments were carried out to identify the residual proteins or peptides. 
These proteins were separated after hydrolysis by immunoprecipitation using the R5 antibody as a 
capturing antibody. The residual proteins from acidic barley and wheat malt autolysates, in addition to 
rye proteins, were analysed and specific proteins with highly similar molecular weights were detected 
from the extracts. It would be interesting to examine more in detail the residual prolamins that are able 
to resist hydrolysis. 
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It is difficult to estimate whether extensive hydrolysis reduces or even abolishes the immunoactivity of 
peptides. Hydrolysing proteins in complex food systems cause the formation of varying amounts of 
different peptides, and the conditions may be difficult to optimize so that the final peptide composition 
is always the same. Testing of the harmfulness of peptides has difficulties, since T-cell tests have 
varying results and in vivo testing is expensive and difficult to perform. Fortunately, an animal model 
in which mice are used to estimate the harmfulness of different prolamin peptides has been developed 
(Freitag et al. 2009). The method was found to be suitable for studies on coeliac disease-causing 
peptides and hydrolysed proteins (Freitag et al. 2011).  
6.4   Effect of extraction on gluten analysis 
Gluten analysis methods, including sample preparation, have been developed for wheat, probably 
because wheat is used more widely in diets compared to rye and barley. In addition, wheat starch is 
frequently used as a basis for gluten-free products. It is therefore important to be able to detect and 
quantify residual wheat prolamins from gluten-free products. Recently, oats were permitted in a gluten-
free diet if their purity from harmful cereal proteins could be ensured. Contamination found in oats has 
been caused as often by barley as by wheat (Gélinas et al. 2008), which makes it more important for the 
analysis method to detect barley prolamins as accurately as wheat prolamins. The prolamins of wheat, 
barley and rye have differences in the solubilities of their subgroups that need to be considered before 
quantitative analysis. While wheat contains high amounts of insoluble prolamins, rye prolamins are 
almost completely soluble in aqueous alcohols. Certain subgroups of barley prolamins demand strong 
reduction and disaggregation before they are solubilized (Shewry et al. 1980, Celus et al. 2006). 
Because of these differences and the importance of accurate detection of barley and rye prolamins, we 
studied and compared different extraction protocols in order to determine the extraction conditions in 
which all of the prolamin subgroups would be extracted. We considered it important for the extraction 
method to be suitable for processed samples, not just for flours. 
We found that prolamins of wheat, barley and rye are most efficiently extracted with 40% 1-propanol 
with 1% DTT at 50 °C. This method was more efficient in the extraction of barley and rye prolamins 
than the most commonly recommended extraction protocol with 60% ethanol. The difference between 
these two alcohols was not so evident with wheat prolamins, as was also observed in the study of 
Wieser et al. (1994), in which the most efficient extraction of gliadins was obtained with either 60% 
ethanol or 50% 1-propanol. However, prolamins of rye and barley are different, and aqueous propanol 
extracts more prolamins from the samples than aqueous ethanol, which has also been noted in several 
previous studies (Lauriére et al. 1976, Shewry et al. 1980, Shewry et al. 1983). In particular, prolamins 
with a polymeric nature, such as B-hordeins, seem to prefer propanolic solutions (Shewry et al. 1980), 
and significant amounts of polymeric prolamins have been reported to co-extract with 1-propanol (Fu 
and Sapirstein 1996, Bean et al. 1998). Charbonnier et al. (1981), however, considered ethanol to be the 
most efficient extractant with respect to purity. Shewry et al. (1983) also noted the presence of proteins 
other than secalins in propanol extraction. Neither SDS-PAGE nor automated electrophoresis, which 
were used in the present study, revealed any significant levels of proteins other than prolamins in the 
meal samples. However, we were unable to identify the prolamin subgroups by automated 
electrophoresis due to the highly dissimilar patterns compared to those in SDS-PAGE.  
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The importance of reduction and an elevated temperature in the efficient extraction of prolamins was 
shown in present study. Monomeric prolamins were readily soluble at RT without reduction, but 
polymeric prolamins needed reduction and heating before they were solubilized. This is in accordance 
with previous studies on wheat and barley prolamins (Shewry et al. 1980, Byers et al. 1983, Fu and 
Sapirstein 1996, Howard et al. 1996). The reduction is needed to break the disulphide bonds between 
the proteins to solubilize them in alcoholic solutions. The location of disulphide bonds has a strong 
influence on the reduction efficiency. The bonds between the proteins break at lower reducing agent 
concentrations; however, the bonds inside the proteins need much higher concentrations of reducing 
agent (Lavelli et al. 1996). Despite reduction, it may still be impossible to get all the proteins into 
solution, because they can exist in large aggregates or be attached to other polymers such as starch or 
lipids. The SDS buffer was also noted to extract residual prolamins from the meal samples after 
alcoholic  extractions  in  our  study  (IV: Figure 3). In addition, heat treatment lowers the solubility of 
proteins. Heating causes the unfolding of proteins, exposing sulphydryl groups that are able to form 
new bonds. These new bonds cause conformational changes in prolamin proteins, resulting in even 
larger protein complexes with a lower solubility (Schofield et al. 1983). Lagrain et al. (2011) observed 
that the same gliadin levels were not extracted after heating, even with reduction, suggesting the 
existence of other bonds in their structure. The -elimination reaction of cysteine, which involves the 
formation of dehydroalanine and free sulphydryl groups in gliadin and glutenin, has been suggested to 
be a possible additional cross-linker between the proteins (Rombouts et al. 2010). The cross-link is 
generated between dehydroalanine and cysteine or lysine; however, this reaction needs alkaline pH 
conditions to occur. Isopeptide bonds between lysine and glutamine or asparagine have also been found 
after heat treatment (Rombouts et al. 2011). 
In addition to the use of reduction, the efficiency of the extraction is increased by elevating the 
temperature. We noted in our study that elevating the extraction temperature from RT to 50 °C 
significantly increased the yield. However, we did not notice any improvement in the efficiency by 
elevating the temperature to 60 °C, which has been used in previous studies (van den Broeck et al. 
2009). The amount of prolamins extracted might also be increased by adding more extraction steps. 
Bean et al. (1998) observed that when wheat prolamins were extracted three times for 5 min with 50% 
1-propanol, only negligible amounts of protein were left in the third fraction, indicating the high 
efficiency of the first two repeats. We considered whether it would be more convenient to have only 
one extraction step before analysis, since then it would be simpler and faster to perform. Although if 
only 5 min extraction times are used, as in the study of Bean et al. (1998), the total extraction time 
would not be much longer, more work is needed to complete multiple extraction steps instead of only 
one.  
Although reduction is an important factor in the extraction of prolamins, reducing agents have been 
noted to interfere with the analysis methods used for gluten detection. Therefore, their usage has to be 
carefully considered before analysis. Reduction agents modify the protein structure, which in turn 
affects to the antibody-antigen reactions, leading to errors in quantitative determination (Doña et al. 
2008). Sufficient dilution of the extracted samples is often necessary. We demonstrated in study IV that 
increasing the level of DTT did not produce a significant increase the prolamin yield, and good 
efficiency could already be obtained with 1% DTT. It should be noted, however, that when reduction is 
used in the extraction process, polymeric prolamins are also extracted and the total gluten fraction is 
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obtained in the solution. In Codex Stan 118-1979, prolamins are described as “the fraction from gluten 
that can be extracted by 40–70% of ethanol.” This is problematic, since the total prolamin fraction, 
including polymeric prolamins, is considered harmful for coeliacs, not only the alcohol-soluble 
fraction. To resolve this, the alcohol-soluble prolamin content is defined in Codex Stan 118-1979 as 
being a half of the total content, and the analysis results are therefore multiplied by two. Obviously, this 
is not the case when reduction is used in sample preparation and the total prolamin fraction is extracted. 
Multiplication by two would then lead to a doubling of the true gluten content.  
Recently, some other studies on prolamin extraction have been published. New interest in the 
extraction of gluten proteins seems to have been raised following the development of new gluten 
analysis methods. Van den Broeck et al. (2009) compared the extraction protocols that are used today 
and developed a new optimized two-step extraction protocol. The protocol included extraction by 50% 
aqueous 2-propanol for 30 min at RT followed by extraction with 50% aqueous 2-propanol, 50 mM 
Tris-HCl (pH 7.5) containing 1% DTT for 30 min at 60 °C. When compared with the other extraction 
protocols, they reported obtaining more complete extraction with a higher gluten protein content, which 
also had higher concentrations of glutenins. Gessendorfer et al. (2010), on the other hand, compared the 
extraction efficiency of a buffered salt solution containing tris(2-carboxyethyl)phosphine (TCEP) and 
guanidine hydrochloride with the commercial cocktail solution and 60% ethanol. The 60% ethanol was 
only  able  to  extract  37%  of  the  prolamins  from  wheat  bread  as  compared  to  the  amount  that  was  
extractable with the cocktail solution. The protein yield was increased to 95% when 20–50 mmol/L 
TCEP was used in the ethanol solution. The addition of guanidine hydrochloride was observed to be 
essential for the quantitative extraction of prolamins. However, we did not observe any advantage in 
using guanidine hydrochloride, since better extraction yields were obtained with 40% 1-propanol than 
with the cocktail solution. On the contrary, it might have caused disturbance, lowering the gluten 
measurements for wheat bread, since the gluten levels were lower when extracted with the cocktail 
solution than with 40% 1-propanol. 
Another factor affecting quantitative gluten analysis is the reactivity of the prolamin-specific antibodies 
with  different  prolamin  subgroups.  The  results  obtained  with  gluten  assays  are  multiplied  by  two  to  
obtain the total gluten content, because it is assumed that only a half of the prolamins are extracted. It 
would also be sensible to double the results if only a half of the gluten proteins were recognized by the 
antibody. However, our Western blot analysis showed that both the -gliadin and the R5 antibody 
recognized the polymeric glutenins, which suggests the possibility of directly quantifying prolamins 
without multiplication (IV: Figure 3), although the affinity of the R5 antibody against glutenins was 
shown to be low (also in Allred and Ritter 2010). In addition to inaccuracies caused by multiplication, 
the diverse reactions between antibodies and prolamin subgroups may cause problems in interpreting 
quantitative results. In accordance with a previous study by Wieser and Seilmeier (1999), which 
demonstrated the variability in antibody affinities against different prolamin subgroups, we also noticed 
clear differences between three prolamin-specific antibodies in their cross-reactivity with prolamins of 
wheat,  barley  and  rye.  The  polyclonal  anti-gliadin  antibody recognised  all  of  the  prolamin  groups  of  
wheat, barley and rye, whereas the -gliadin antibody mainly recognized the high molecular weight 
proteins of wheat, barley and rye and the antibody R5 the medium molecular weight prolamin groups. 
The polyclonal anti-gliadin antibody and the R5 antibody recognized some of the water and salt-soluble 
proteins  of  wheat  and  rye,  indicating  the  presence  of  prolamins  in  these  fractions.  It  was  noted  that  
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moderate salt solutions can increase the solubility of prolamins. Fu et al. (1996) observed that 2% NaCl 
in distilled water extracted almost all gliadins and most of the glutenins. Only the -gliadins were not 
entirely solubilized. They suggested that salt induces conformational changes in the protein structure 
and consequently makes them more readily soluble in water. However, increasing the salt 
concentration reduced the solubility of higher molecular weight gliadins and glutenins (Kim and 
Bushuk 1995). If Osborne fractionation is used, water and salt-soluble albumins and globulins are 
removed before the extraction of prolamins. Based on the observations of Fu et al. (1996) and the 
results of our study, some of the prolamins may be removed with these fractions. However, if no pre-
extraction with salt solution is performed, some albumins and globulins are solubilised with prolamins 
into the alcohol solution. It has been reported that albumins and globulins are extracted with 50% 1-
propanol in addition to prolamins (Fu and Sapirstein 1996). However, when using an immunological 
method for quantification, this should not be a problem, since the prolamin-specific antibodies should 
not react with proteins other than prolamins. The defatting procedure that is sometimes used prior to 
the extraction of prolamins from certain food products, such as sausages, also influences the 
immunological analysis of prolamin proteins with ELISA assays of R-Biopharm and ImmunoTech, a 
Beckmann  company  (Gabrovská  and  Rysová  2004).  The  gliadin  content  of  wheat  flour  after  hexane  
extraction was close to the original sample; however, the quantitative gliadin content almost doubled 
after chloroform extraction and decreased almost to a half after petrol ether extraction. Rye meal 
defatting with water-saturated 1-butanol before extraction by 60% ethanol resulted in a 40% loss of the 
secalin yield (Charbonnier et al. 1981). Due to these problems, we did not use defatting for our 
samples. However, this was not necessary because of their low fat content. 
It is a challenge to accurately quantify prolamins due to their high complexity and the sensitivity to 
disturbances of ELISA analysis. Nevertheless, the extraction protocol should allow the complete 
extraction of different prolamins from wheat, barley and rye, maintaining their immunoreactivity with 
detecting antibodies. The complexity of prolamins also affects antibody recognition, since some 
prolamin subgroups are recognized more intensively than others. This highlights the importance of a 
suitable standard for the analysis. The ideal situation would be where the standard is composed of the 
same prolamin subgroups and in similar relative proportions to those present in the sample. 
6.5   Modification of gluten by deamidation 
Food proteins are influenced by process treatments, including isolation, purification, modification and 
drying procedures, and the presence of other food constituents. Proteins may have also been hydrolysed 
into smaller peptides during the process, e.g. in fermentation processes and brewing. Some food 
products undergo extrusion or enzymatic treatments during processing, both of which influence the 
structure and solubility of the proteins. In addition to the changes caused by processing, proteins can be 
deliberately modified to improve their functional properties and their applicability in foods. All of these 
treatments affect the surface structure of proteins, which consequently affects antibody binding and 




Deamidation significantly decreased the recognition of gluten proteins and peptides by monoclonal R5, 
-gliadin and G12 antibodies (V: Figure 1–4). Two types of deamidation of prolamin-derived peptides 
were investigated: random and specific deamidation by tTG. Random deamidation modelled the 
possible situation that could occur during food processing, whereas specific deamidation caused by the 
tTG enzyme modelled the harmful peptides with increased immunoactivity in coeliac disease. Both 
types significantly reduced the intensities. This was observed in our study and also in that of 
Kahlenberg et al. (2004) with deamidated epitopes of 33mer. In addition, Morón et al. (2008a) reported 
the decreased ability of G12 and A1 antibodies to recognize deamidated 33mer. In addition, 
deamidation of intact gluten proteins decreased or abolished the recognition of the proteins by the 
antibodies. This may have serious consequences if deamidated gluten proteins ended up in products 
that were generally considered gluten-free, e.g. milk or meat products. Since gluten is a cheap by-
product of the starch industry, its usage may increase and deamidated gluten proteins may consequently 
be found in increasing numbers of food products. In addition, gluten is a vegetable protein, which 
further increases the interest its use in various foods.  
Deamidation is used to increase the poor solubility of gluten proteins and improve their foam and 
emulsion forming cababilities. Deamidation in food processes may be induced by acidic or enzymatic 
treatments. Deamidation has also been shown to be an important factor in coeliac disease, since it 
changes prolamin peptides to forms that are recognized by HLA-DQ2 and -DQ8 molecules. This type 
of deamidation is caused by tTG. Deamidation by tTG increases their harmfulness to coeliac patients 
(Molberg et al. 1998, Sjöström et al. 1998; van de Wal et al. 1998b). It has been observed that some 
peptides that are not recognized in their native form may be recognized after specific deamidation of 
glutamine residues. For example, deamidation of wheat and maize prolamins with microbial 
transglutaminase increased the immunoglobulin A reactivity of coeliac disease patients, suggesting that 
gluten-free maize may also cause a risk to people with coeliac disease, especially after treatment with 
microbial transglutaminase (Cabrera-Chavez et al. 2008). It is not known, however, whether 
deamidation induced by acid treatment increases or reduces the harmfulness of prolamin peptides. 
Terreaux et al. (1998) observed an increase in the affinity of gliadin peptides to HLA molecules after 
chemical  deamidation,  whereas  Berti  et  al.  (2007)  noted  in  their  study  that  chemical  deamidation  by  
acid and heat treatment lowered the immunoreactivity, while tTG-catalysed deamidation increased the 
immunoreactivity.  Therefore,  they  suggest  that  chemical  deamidation  could  be  used  to  lower  the  
reactivity of residual gluten and consequently reduce the harmful effect. Deamidation by tTG is highly 
specific, and the locations of proline residues in the amino acid sequence determine which glutamines 
are deamidated (Vader et al. 2002a), whereas acidic deamidation is random and any of the glutamines 
may be deamidated. Because of the random nature, it is difficult to estimate the behaviour of the 
randomly deamidated peptides with HLA molecules. The immune response is highly specific to certain 
sequences, and even the smallest changes in the amino acid sequence may either abolish or create an 
immune response (Ellis et al. 2003). Therefore, preventing deamidation could be used as a novel 
therapy in coeliac disease. 
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Deamidation influences the accuracy of quantification by immunoassays, because it changes the 
protein surface structure. The antibodies used for gluten quantification are raised against proteins or 
peptides of native proteins, and their ability to accurately detect modified proteins can therefore 
substantially differ due to differing affinity between the antibody and the antigen. The modified gluten 
can actually be more immunoreactive compared to native gluten, and at the same time difficult to 




7   CONCLUSIONS 
The main findings of the present work were that quantitative gluten analysis can be greatly improved 
by selecting a better standard for the analysis and using 40% 1-propanol with 1% DTT at 50 °C for the 
extraction of prolamins. With these procedures, the unrealistic results obtained for products containing 
barley can be corrected, and furthermore, no multiplication of the results is necessary to obtain the total 
gluten content. However, the results also showed that deamidation of gluten proteins considerably 
reduced the antibody reaction, which would lead to the substantial underestimation of gluten contents.  
Gluten analysis methods have considerably developed since the first standard was set for gluten-free 
products in 1979. At that time the maximum gluten content allowed in gluten-free products was 
expressed in terms of the level of total nitrogen, while we now measure the actual harmful sequences 
from the samples. This means that a great deal of knowledge has been obtained on the pathogenesis of 
coeliac disease, which has been used in the development of new analysis methods. Despite the 
progress, there is still no accurate method to detect barley prolamins from beer that would give the total 
gluten content. Another still unresolved problem concerns the evaluation of contaminations in gluten-
free products. The present study revealed that the R5 antibody, which is the antibody in the currently 
recommended method, overreacts with hordeins, leading to unrealistic results. It was shown that more 
realistic results are obtained if a standard that more closely resembles the sample proteins is used. 
However, in most cases it would be impossible to select the appropriate standard, and whether a 
standard that is a mixture of harmful prolamins would give more accurate results should be tested. The 
remaining difficulty is how to relate the obtained results to the maximum gluten levels that are set by 
the Codex Alimentarius. Nevertheless, we recommend the use of a hordein standard with samples 
containing barley. 
Promising  results  were  obtained  with  the  rye  sourdough  systems,  in  which  secalins  were  efficiently  
degraded. Both the sandwich and the competitive method of R5 gave comparable results. In our study, 
secalins were observed to behave in a very similar manner in sandwich R5 ELISA when compared to 
the gliadin standard of the assay. However, it shoud be noted that the majority of rye prolamins in 
sourdoughs are extracted without reduction and recognized by the R5 antibody. Consequently, the 
doubling of the results, as advised when performing an analysis with a sandwich method, would lead to 
overestimation of true secalin content. 
Sample preparation is an important part of the analysis and should take into account the differences 
between prolamins of wheat, barley and rye. However, many of the reagents that are used to obtain 
efficient extraction interfere with the analysis by immunological assays. Therefore, a compromise is 
needed between the yield and retaining the immunoactivity of proteins. It is useless to use extraction 
methods that reduce protein immunoreactivity, but efficient extraction of prolamins is necessary. Our 
results demonstrated the superiority of 1-propanol over ethanol in the extraction of prolamins, and the 
use of 1-propanol is therefore recommended together with 1% DTT. 
The modification of gluten proteins presents another obstacle for the analysis methods. The methods 
should not only recognise and accurately quantify different prolamin subgroups, but also quantify 
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modified prolamins. Modification by deamidation significantly lowered the affinity against gluten 
proteins of all of the tested antibodies. It would not be a problem if modification reduced the 
harmfulness of the proteins, but this not probable. In fact, the deamidation by tTG after ingestion and 
digestion of gluten is shown to increase their affinity to HLA molecules and consequently increase the 
harmful immune reaction in coeliac patients. The decrease in the detection of deamidated proteins may 
allow products containing high amounts of deamidated gluten be sold as gluten-free and create a 
potential threat to people with coeliac disease.   
Although people with coeliac disease can eat gluten-free products without the fear of being exposed to 
high levels of harmful proteins, considerable work still needs to be done with gluten analysis methods. 
The recommended method based on the R5 antibody is known to detect several unharmful proteins in 
addition to overreaction with hordeins, which may unnecessarily reduce the variety of gluten-free 
products. Hopefully, new methods that are thoroughly tested with commercial food samples containing 
several ingredients that may affect the antibody-antigen reaction will soon be introduced for gluten 
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